The following discussion of our financial condition and results of operations
should be read in conjunction with our Consolidated Financial Statements and
related notes in Part II, Item 8. Financial Statements and Supplementary Data of
this 2020 Form 10-K. For further discussion regarding operating and financial
data for the year ended December 31, 2019 as compared to the year ended
December 31, 2018, refer to Item 7, Management's Discussion and Analysis of
Financial Condition and Results of Operations, in our Annual Report on Form 10-K
for the fiscal year ended December 31, 2019.
In 2020, we updated the presentation of the Company's segment reporting see,
Part II, Item 8. Financial Statements and Supplementary Data; Note 18 Segment
Reporting in the Consolidated Financial Statements for further information. As a
result of these changes in segment reporting, all applicable historical segment
information has been recast to conform to the new presentation. We are also
presenting amounts for the year ended December 31, 2018 in the Results of
Operations Revenues and Segment Profitability tables below, but not the
comparative discussion as mentioned above.

In addition, we updated service lines to reflect the remaining Hazardous Waste
Solutions Services and Manufacturing and Industrial Services in RWCS. This
reclassification is driven by the divestiture of the Environmental Solutions
business, discussed in Part II, Item 8. Financial Statements and Supplementary
Data; Note 4 Restructuring, Divestitures, and Impairments, and service line
information has been recast to conform to the new presentation.
Overview
Incorporated in 1989, Stericycle is a U.S. based business-to-business services
company and leading provider of compliance-based solutions that protects people,
promotes health and safeguards the environment. Stericycle serves customers in
the U.S. and 17 other countries worldwide with solutions for regulated waste and
compliance services, secure information destruction and patient engagement. To
our customers, team members and the communities we serve, Stericycle is a
company that protects what matters.
Our offering of services appeals to a wide range of business customers. The
majority of our customers are healthcare businesses (hospitals, physician and
dental practices, outpatient clinics, long-term care facilities, etc.). We also
provide services to retailers, manufacturers, financial services providers,
professional services providers, governmental entities and other
businesses. While we manage large volumes of waste and other materials, the
volume per customer site on average is small.
Highlights for the year ended December 31, 2020 compared to the prior year
include:
•Revenues for the year ended December 31, 2020 were $2.68 billion, compared to
$3.31 billion in 2019. Of the $633.4 million decline, the impact of divestitures
was $483.7 million and lower SID revenues, excluding SOP pricing, was
$157.1 million, primarily reflecting pandemic-related business disruption. This
was partially offset by growth in Regulated Waste and Compliance Services of
$36.5 million.
•Income from operations for the year ended December 31, 2020 was $31.9 million,
compared to a loss from operations of $211.9 million in 2019. The change was
primarily due to no goodwill impairment in 2020 compared to goodwill impairment
of $228.3 million in 2019, offset by net divestiture losses of $123.6 million in
2020 compared to net divestiture losses of $103.0 million in 2019 for a net
divestiture difference of $20.6 million. In addition, we continue to see lower
charges associated with our key priorities and other significant matters
discussed below.
•Net loss for the year ended December 31, 2020 was $57.3 million, or $0.63
diluted loss per share, compared with $346.8 million, or $3.81 diluted loss per
share, in 2019. The difference was related to higher income from operations of
$243.8 million, lower interest expense of $36.4 million and lower loss on early
extinguishment of debt of $23.1 million, which were partially offset by a higher
income tax expense of $16.7 million.
•Cash flow from operations for the year ended December 31, 2020 was $530.2
million, compared to $248.0 million in 2019, representing a $282.2 million
year-over-year improvement.
•Cash paid for capital expenditures for the year ended December 31, 2020 was
$119.5 million compared to $194.2 million for the year ended December 31, 2019,
primarily driven by the timing of 2019 investments in the ERP and disciplined
capital management throughout 2020.
2020 10-K Annual Report      Stericycle, Inc. • 35


--------------------------------------------------------------------------------

Table of Contents PART II




During 2020, we completed the following debt related transactions:
a)  On November 9, 2020, we issued $500.0 million at par of aggregate principal
Senior Notes, due January 2029, which are unsecured and bear interest at 3.875%
per annum, payable on January 15 and July 15 of each year.
b)  On February 25, 2020, we executed the Fifth Amendment which amended the
Credit Agreement to, among other things:
•increase the maximum allowable Consolidated Leverage Ratio to 5.00 to 1.00
until the end of the first quarter of 2022 and 4.50 to 1.00 thereafter.
•upon the consummation of the divestiture of the ESOL Disposal Group, each of
the foregoing maximum permitted Consolidated Leverage Ratio levels were stepped
down to 4.75 to 1.00 and 4.25 to 1.00, respectively.
•allow for continuation of the $200 million of cash add backs to EBITDA through
December 31, 2020 and addbacks of $100 million until December 31, 2021, with no
further addbacks thereafter.
•increase the leverage ratio pricing tier of greater than 4.50 to 1.00 by
0.125%.
•grant a first-priority security interest to the administrative agent for the
benefit of the lenders in substantially all of the personal property of the
Company and certain of its material domestic subsidiaries, including certain
equity interests held by those entities.
For additional information, see Part II, Item 8, Financial Statements and
Supplementary Data; Note 9 - Debt in the Consolidated Financial Statements.
Over the course of 2020, we divested our Environmental Solutions business,
Expert Solutions business, both reported primarily in our North America
reportable segment and operations in Argentina, in our International reportable
segment. Divestiture transactions combined generated $498.9 million in net
proceeds during 2020 that was primarily used to repay debt. For additional
information, see Part II, Item 8, Financial Statements and Supplementary Data;
Note 4 - Restructuring, Divestitures, and Impairments in the Consolidated
Financial Statements.
COVID-19 Pandemic
In March 2020, the World Health Organization declared the COVID-19 virus
outbreak a pandemic. The COVID-19 pandemic has had a global economic impact,
including temporary closure of non-essential businesses worldwide and
postponement of elective surgeries and preventative care. The Company continues
to maintain operations within all business service offerings, although our
maritime waste service offering has been significantly and adversely impacted.
We are monitoring future implications of the COVID-19 pandemic and continue to
take actions to manage spending to align to operational requirements.

The Company's COVID-19 pandemic response has included efforts to protect the
health and well-being of our workforce and our customers. We worked proactively
with the Centers for Disease, Control and Prevention, the Occupational Safety
and Health Administration, the Department of Transportation and regulatory
agencies around the world to ensure readiness for proper regulated waste
management. We have updated and implemented numerous protocols specifically to
reduce risk among our front-line team members, and our strategic sourcing team
has worked diligently to take measures to provide our field operations employees
with appropriate personal protective equipment. We've staggered shift times and
dedicated trucks to specific drivers to reduce exposure. We've implemented more
rigorous cleaning protocols for all our facilities. Since March of 2020, we had
more than 7,000 team members around the globe sheltering in place, all to
protect our staff and communities we serve. We will continue to monitor the
safety of our team members as a result of the COVID-19 pandemic, but the
long-term impact is not known at this point as the scale and severity of the
outbreak and related behavioral changes is still uncertain. Additionally, we
increased the frequency of our communications with our Board of Directors. At
the height of the pandemic, we provided weekly updates to our Board. This
communication kept the Board apprised of the evolving impacts of the pandemic to
our organization and team members, as well as provided them an opportunity to
understand and monitor our response to the pandemic while providing oversight
and guidance.

The Company has taken a leadership position related to the COVID-19 pandemic to
support our customers and provide industry expertise regarding the effective
management of COVID-19 waste.
2020 10-K Annual Report      Stericycle, Inc. • 36


--------------------------------------------------------------------------------

Table of Contents PART II





The impact of the COVID-19 pandemic across our revenue service categories is as
follows:
  Revenue Service Category     Services Offered          COVID-19 Pandemic Impact
                                                    RWCS's transportation and treatment
                                                    facilities have remained open to
                                                    provide safe and compliant disposal
                                                    of regulated waste. As a leader in
                                                    this industry, we are helping our
                                                    healthcare and retail customers
                                                    manage multiple aspects of the
                            • Regulated waste       vaccine rollout. This includes
                            management services     compliant waste collection,
                            (including reusable     transportation, and waste treatment
                            sharps container        of expired vaccines, partially used
                            disposal management     vaccines, sharps, packaging, and
                            services)               expunged syringes with trace
                            • Pharmaceutical waste  amounts of vaccines.
                            services, including     Revenues for RWCS showed growth
                            controlled substances   over last year despite the impact
    Regulated Waste and     (CsRX, Kiosk, and       on maritime waste services from the
    Compliance Services     Seal/Send)              pandemic.
                            • Compliance programs   The COVID-19 pandemic has also
                            under the Steri-Safe®,  created new needs for healthcare
                            Clinical Services and   testing centers for the COVID-19
                            First Practice          virus across America as well as the
                            Management brand names  disposal of non-healthcare waste
                            • Hazardous waste and   and vaccine related waste. We
                            compliance solutions    continue to provide services to
                            • Maritime waste        testing centers and our expanding
                            services                non-healthcare waste customer base
                                                    and have begun servicing vaccine
                                                    waste. In our international
                                                    markets, we have more
                                                    transactional-based agreements
                                                    which has resulted in revenue
                                                    growth as a result of returning
                                                    elective surgeries combined with
                                                    increased COVID-19 waste volumes.
                                                    While still below pre-pandemic
                                                    levels, Secure Information
                                                    Destruction revenues continued to
                                                    improve since the start of the
                                                    pandemic in March and remained
                            • Secure information    consistent sequentially with the
                            destruction (including  third quarter despite continued
                            document and hard drive economic pandemic impacts in the
                            destruction services)   fourth quarter. The revenues and
                            under the Shred-it®     stops in the fourth quarter aligned
     Secure Information     brand name which        with local, regional and country
    Destruction Services    includes regular        level lock-downs. While recent
                            scheduled services (and shutdowns in the late fourth
                            processing onsite and   quarter have impacted our stops
                            offsite) and one-time   serviced, we expect stops serviced
                            services (select,       to improve as economies re-open.
                            priority and express)   In North America, SID organic
                                                    revenues were down 12.9 percent
                                                    compared to 2019, which reflects a
                                                    decrease in service stops.
                                                    Additionally, Internationally, SID
                                                    organic revenues were down 21.3
                                                    percent compared to 2019.
                            • Appointment           At the end of the first quarter and
                            reminders, secure       through the year ended 2020, we
     Communication and      messaging, event        observed lower demand for services
      Related Services      registration and other  due to the pandemic. When excluding
                            communications          the impact of divestitures and
                            specifically for        foreign exchange, revenues declined
                            hospitals and IDN's     $14.4 million.


Key Business Priorities

•Quality of revenue - We have been executing against our foundational
initiatives we launched to drive revenue quality. These included a formal
cross-functional deal review committee, realignment of sales incentive plans,
re-organization of our commercial leadership team around our service lines, key
customer channels, and implementation of global customer pipeline management
processes for both Regulated Waste and Compliance Services and Secure
Information Destruction. In combination with our quality of revenue initiatives,
we continue to develop and deploy innovative solutions to meet unmet customer
needs, strengthen customer engagement, and drive long-term organic growth. As an
example, during 2020, Regulated Waste and Compliance Services innovated to meet
customer needs during the pandemic by
2020 10-K Annual Report      Stericycle, Inc. • 37


--------------------------------------------------------------------------------

Table of Contents PART II

rapidly deploying solutions to support temporary COVID-19 testing centers and to introduce non-health care PPE disposal options. In Secure Information Destruction Services, we deployed express and priority offerings to address unmet customer needs around service speed and predictability during the pandemic.



•Operational efficiencies - As we manage through volatile times, we remain
focused on operational efficiencies, modernization and innovation to control
variable and discretionary costs and improving performance and efficiencies in
our field operations. Our Engineering and Operations teams have and will
continue to implement operational process and performance improvements, which
have significantly contributed to our gross profit margin expansion of 390 basis
points for the year ended December 31, 2020. We are gaining traction on right
sizing and balancing our fleet and equipment; driving efficiencies in route and
long-haul planning; and optimizing our network and assets. Additionally, we have
normalized our workforce following the furloughs experienced earlier this year.

•Debt reduction and leverage improvement - We have reduced net debt by
approximately $900.0 million during the year ended December 31, 2020. We applied
$498.9 million in net proceeds from the divestiture of Expert Solutions,
operations in Argentina and Environmental Solutions to the repayment of debt
during December, August and April 2020, respectively. With the divestitures
proceeds and our continued focus on operating margin expansion and free cash
flow generation, we reduced our adjusted debt to EBITDA leverage ratio as
defined by our Credit Agreement to 3.54 times as of December 31, 2020. We have
$947.2 million as of December 31, 2020 available under our Senior Credit
Facility, which matures in November 2022.

•Portfolio rationalization - On December 2, 2020, Stericycle divested Expert
Solutions for approximately $78.0 million in cash. On August 3, 2020, Stericycle
divested all of our operations in Argentina for approximately $3.9 million in
cash. On April 6, 2020, we also divested the Environmental Solutions business
for $462.5 million in cash. We expect to continue to evaluate opportunities to
further optimize our portfolio of businesses.

•ERP implementation - We entered 2020 with a schedule to begin the staged
deployment of the commercial, operational and financial systems in North
America. Our first stage included the implementation of a human capital
management system which was completed in January 2020. However, guided by our
commitment to protect what matters, we concluded that the health and travel
risks associated with a field deployment in the COVID-19 pandemic environment
were substantial, and given our priorities to serve our customers and keep our
team members safe, we made the decision to defer the ERP deployment to 2021. In
the interim, we are making progress mining data from our legacy systems and
tools to gain business insights, build scorecards and improve performance.
Additionally, over the past several months, we accelerated the roll-out of
certain technologies associated with our North American ERP system, including
our new employee travel and expense system and a global tax management system.
Key Priorities and Other Significant matters
The following table identifies key priorities and other significant matters
impacting our business (amounts are stated pre-tax except when noted):
2020 10-K Annual Report      Stericycle, Inc. • 38


--------------------------------------------------------------------------------


  Table of Contents         PART II


In millions
                                                            Year Ended December 31,
                                                               2020                2019
Pre-tax items:
Included in COR
Business Transformation                               $          -               $   0.4
Operational Optimization                                         -                   9.8
Asset Impairments                                              6.8                   5.2
Total included in COR                                          6.8                  15.4

Included in SG&A
Business Transformation                                       50.8                  67.3
Intangible Amortization                                      124.9                 145.2
Acquisition and Integration                                      -                   3.5
Operational Optimization                                       3.1                   4.7
Divestitures                                                   9.4                  11.7
Litigation, Settlements and Regulatory Compliance             20.3                  28.2
Asset Impairments                                              8.7                  16.9
Other                                                          9.1                  39.7
Total included in SG&A                                       226.3                 317.2

Divestiture losses, net of gains                             123.6                 103.0

Goodwill impairment                                              -                 228.3

Total included in Income (loss) from operations              356.7          

663.9



Included in Interest expense, net
Capital Allocation (debt related)                                -          

3.6



Loss on early extinguishment of debt                             -          

23.1



Included in Other expense, net
Other (including highly inflationary exchange loss)            1.2                   3.3
Total pre-tax                                         $      357.9               $ 693.9

After tax items:

CARES Act                                             $      (44.4)              $     -
Total after-tax                                       $      (44.4)              $     -


The above priorities and other significant matters include the following types
of activities:
                                                                     Cash Charges
                                  Closure and Exit                             Consulting and
                                      Costs(1)          Internal (2)         Professional Fees          Other (3)         Non-Cash Charges (4)
Business Transformation                  ü                   ü                       ü                      ü                      ü
Acquisition and Integration              ü                   ü                       ü                      ü                      ü
Operational Optimization                 ü                   ü                       ü                      ü                      ü
Divestitures                                                                         ü                      ü                      ü
Litigation, Settlements and
Regulatory Compliance                                                                ü                      ü
Other                                                                                ü


(1)Includes employee and contract termination, facility closure and clean-up
costs.
(2)Includes dedicated resources, including project related incentive
compensation and stock-based compensation.
2020 10-K Annual Report      Stericycle, Inc. • 39


--------------------------------------------------------------------------------

Table of Contents PART II

(3)Includes other costs related to each priority (e.g. software maintenance fees, changes in contingent consideration and environmental provisions). (4)Includes impairments, accelerated depreciation and/or amortization, gain/loss on disposal and changes in deferred consideration. Business Transformation



For the years presented and for the cumulative period since the inception of
Business Transformation, we have recognized the following, principally reported
in Other:
In millions
                                                                   Year Ended December 31,
                                                                                                   Cumulative Since
                                                                2020                2019              Inception
ERP development and implementation
Consulting and professional fees                           $       21.8          $   27.2          $        65.0
Internal labor                                                     13.1               9.3                   31.2
Software usage/maintenance fees                                    12.1              15.3                   34.8
Other related expenses                                              3.8               4.3                    9.7
Operating expenditures                                             50.8              56.1                  140.7
Capital expenditures                                               51.3              80.6                  160.8
Total ERP related                                                 102.1             136.7                  301.5

Investment in cost savings and other related matters                  -              11.6                   91.7

Total charges and capital expenditures                     $      102.1

$ 148.3 $ 393.2



Non-cash charges                                           $        2.0          $    1.8          $        15.6
Cash charges and stock based compensation                          48.8                 65.9                  216.8
Total operating expenditures                               $       50.8

$ 67.7 $ 232.4





Through 2019, we had completed activities originally contemplated as part of
Business Transformation in the areas of investment in cost savings and business
capability and other related matters. We have shifted the planned deployment of
the rest of our North American ERP system until 2021. In the interim, we
accelerated the deployment of certain technologies associated with our North
American ERP system, including our new employee travel and expense system and a
new global tax management system.


Intangible Amortization
See table above of key priorities and other significant matters for intangible
amortization expense from acquisitions for the years presented and how they are
classified in the Consolidated Statements of Loss.

The decrease in amortization expense is a result of the reduction of intangible
assets related to divestitures. See Part II, Item 8. Financial Statements and
Supplementary Data; Note 7 - Goodwill and Other Intangible Assets in the
Consolidated Financial Statements for further information.
For intangible amortization by segment see Part II, Item 8. Financial Statements
and Supplementary Data; Note 18 - Segment Reporting in the Consolidated
Financial Statements.
Acquisition and Integration

See table above of key priorities and other significant matters for acquisition
and integration expense for the years presented, primarily in Other, and how
they are classified in the Consolidated Statements of Loss.

Details of the acquisition completed in the year ended December 31, 2019 can be
found in Part II, Item 8. Financial Statements and Supplementary Data; Note 3 -
Acquisitions in the Consolidated Financial Statements.
2020 10-K Annual Report      Stericycle, Inc. • 40


--------------------------------------------------------------------------------


  Table of Contents         PART II


Operational Optimization

Our organization is focused on operation efficiency, modernization and
innovation. The aim of our focus is to achieve a culture of continuous
improvement that will enhance efficiency, effectiveness and competitiveness to
improve our cost base and cash flow and we have taken a number of actions to
reduce operating costs and optimize operations. For example, we believe plant
throughput and route density are competitive strengths of Stericycle. We
maintain such strengths by making adjustments to our network of transportation
and treatment facilities, standardizing containers and right sizing fleet levels
in an effort to optimize overall logistics and processing capabilities within a
service category while reducing operational costs. As part of these efforts, we
seek to reduce network redundancies by consolidating facilities, closing
redundant facilities, optimizing containers and fleet levels and restructuring
the local organization and operations for efficiency.

We recognized the following Operational Optimization expenses: In millions


                                           Year Ended December 31,
                                               2020                 2019
North America
Exit costs - employee termination   $          -                  $  1.4
Closure and exit costs - other                 -                       -
Non-cash charges                               -                     2.4
Other expenses                                 -                       -
Total                                          -                     3.8

International
Exit costs - employee termination              -                     0.9
Closure and exit costs - other                 -                     2.4
Non-cash charges                             2.8                     4.9
Other expenses                               0.3                     2.5
Total                                        3.1                    10.7

Total Operational Optimization      $        3.1                  $ 14.5


As we continue to consider each Operational Optimization activity, the amount,
timing and recognition of charges will be affected by the occurrence of
commitments and triggering events as defined under U.S. GAAP, among other
factors. We may incur more charges, cash expenditures, accelerated depreciation
and impairments than estimated and may not realize the expected improvement or
cost savings on the planned time frame or at all. See Part II, Item 8. Financial
Statements and Supplementary Data; Note 4 - Restructuring, Divestitures, and
Impairments in the Consolidated Financial Statements.
Divestitures
We evaluate our portfolio of services on an ongoing basis with a
country-by-country and service line-by-service line approach to assess long-term
potential and identify potential business candidates for divestiture. Our
decisions regarding divestitures are based upon the following criteria:
•outlook for long-term market conditions;
•potential impact to complementary services or customer relationships;
•ability to leverage infrastructure and customer base for growth;
•potential for margin improvement;
•current divestiture value versus future divestiture value;
•ongoing capital requirements of the business;
2020 10-K Annual Report      Stericycle, Inc. • 41


--------------------------------------------------------------------------------

Table of Contents PART II

•return on invested capital; •impact on overall leverage, including impact on debt leverage ratio; •implications for our internal control remediation efforts; and •implications for our new ERP system implementation.



We recognized the following Divestitures (including Divestiture losses (gains),
net) in the Consolidated Statements of Loss:
In millions
                                                                        Year Ended December 31,
                                                                        2020                 2019
North America Segment
Domestic Environmental Solutions business                          $       53.8          $       -
CRS business                                                              (38.8)              45.5

Total North America charges, net                                           15.0               45.5
International Segment
CRS business                                                               (4.0)                 -
Argentina operations                                                      112.4                  -
Mexico operations                                                          (4.9)              43.2
Chile operations                                                            5.1               19.0
U.K. businesses                                                               -               (4.7)
Total International charges, net                                          108.6               57.5
Divestiture losses (gains), net                                           123.6              103.0
Consulting, professional, and other fees (in SG&A)                          9.4               11.7

Total Divestitures (including Divestiture losses (gains), net) $ 133.0 $ 114.7




For additional information regarding Divestiture losses (gains), including
significant impacts of foreign currency translation adjustments, net, see Part
II, Item 8. Financial Statements and Supplementary Data; Note 4 - Restructuring,
Divestitures, and Impairments in the Consolidated Financial Statements.
We continue to evaluate the performance of our entire portfolio of assets and
businesses. Divestitures resulting from this evaluation may cause us to record
significant charges, including those related to goodwill, other intangible
assets, long-lived assets, and cumulative translation adjustments. In addition,
divestitures we complete may not yield the targeted improvements in our
business. Any charges that we are required to record or the failure to achieve
the intended financial results associated with the portfolio rationalization
evaluation could have a material adverse effect on our business, financial
condition or results of operations (see Part II, Item 8. Financial Statements
and Supplementary Data; Note 4 - Restructuring, Divestitures, and Impairments in
the Consolidated Financial Statements).
Litigation, Settlements and Regulatory Compliance
We operate in highly regulated industries and must address regulatory inquiries
or respond to investigations from time to time. We are also involved in a
variety of civil litigation from time to time including the items detailed in
Part II, Item 8. Financial Statements and Supplementary Data; Note 20 - Legal
Proceedings, in the Consolidated Financial Statements.

See table above of key priorities and other significant matters for litigation,
settlement and regulatory compliance charges, primarily consulting and
professional fees, contingent liability provisions and settlements, net of
insurance recoveries, impacting our business for the years presented, primarily
in Other, and how they are classified in the Consolidated Statements of Loss.
2020 10-K Annual Report      Stericycle, Inc. • 42


--------------------------------------------------------------------------------

Table of Contents PART II




Asset and Goodwill Impairments
Impairment charges comprise the following:
In millions
                                                         Year Ended December 31,
Asset impairments:                                          2020                2019
Property plant and equipment                       $       6.8                $   5.2
Impairments included in COR                                6.8                    5.2

Property plant and equipment                               0.2                    0.5
Customer lists, permits and tradenames                     8.5                   16.4
Impairments included in SG&A                               8.7                   16.9

Total Asset impairments                            $      15.5                $  22.1

Goodwill impairments:
Canada reporting unit                              $         -                $ 126.6
Domestic Environmental Solutions reporting unit              -                   80.8

Latin America reporting unit                                 -                   20.9
Goodwill impairments                               $         -                $ 228.3


Impairment charges may be recognized in future periods to the extent changes in
factors or circumstances occur, including deterioration in the macroeconomic
environment or in the equity markets, including the market value of our common
shares, deterioration in our performance or our future projections, or changes
in our plans for one or more reporting units or specified long-lived assets,
among other factors.
For additional information on asset and goodwill impairments, see Part II, Item
8. Financial Statements and Supplementary Data; Note 4 - Restructuring,
Divestitures, and Impairments and Note 7 - Goodwill and Other Intangible Assets
in the Consolidated Financial Statements.
Other
See table above of key priorities and other significant matters for other
charges, primarily consulting and professional fees related to internal control
remediation activities as well as the implementation of new accounting
standards, impacting our business, primarily in Other, for the years presented
and how they are classified in the Consolidated Statements of Loss.

See table above of key priorities and other significant matters for the impact
of foreign exchange re-measurement of net monetary assets held in Argentina as a
result of its designation as a highly inflationary economy for the years
presented and how they are classified in the Consolidated Statements of Loss.
Argentina operations were divested in August 2020.
Capital Allocation
Stericycle aims to maintain a structured capital allocation strategy that
balances investment in the business, debt reduction and returns to shareholders.
Our current capital allocation strategy includes debt reduction and investments
in our business.
For the year ended December 31, 2019, we incurred a pre-tax loss on early
extinguishment of debt of $23.1 million, comprising a "make-whole" premium of
$20.4 million, due under the terms of certain of the private placement notes and
$2.7 million related to unamortized debt issuance costs, associated with
repayments of our private placement notes.
We also incurred $0.2 million of debt modification charges associated with the
execution of the Fourth Amendment, which are recorded in Interest expense, net
and charges of $3.4 million related to the write-off of the unamortized portion
of premiums associated with interest rate locks executed in connection with the
issuance of certain of the private placement notes, which are recorded in
Interest expense, net.
CARES Act and Tax Reform
2020 10-K Annual Report      Stericycle, Inc. • 43

--------------------------------------------------------------------------------

Table of Contents PART II




For further discussion, see Part II, Item 8. Financial Statements and
Supplementary Data; Note 10 - Income Taxes in the Consolidated Financial
Statements.
Results of Operations
Revenues (including Segment Revenue):
Our various regulated services share a common infrastructure and customer
base. We market our regulated and compliance services by offering various
pricing options to meet our customers' preferences and customers move between
these different billing paradigms. For example, our customers may contract with
us for regulated waste disposal services that are billed based on the weight of
waste collected, processed and disposed during a particular period and in a
subsequent period, the same customer could move to our standard service, which
packages the same regulated waste services with training and education services
for a contracted subscription fee. Another example is a customer that purchases
our regulated waste disposal and sharps disposal management services which
provides the customer with the same regulated services under a different pricing
and billing arrangement.
We do not track the movement of customers between the various types of regulated
services we offer. Although we can identify directional trends in our services,
because the regulated services are similar in nature and there are inherent
inaccuracies in disaggregation, we analyze revenues by revenue service category
and operating segment. We analyze our revenue growth by identifying changes
related to organic growth, acquisitions, divestitures and changes due to
currency exchange fluctuations. Organic growth excludes the effect of foreign
exchange and acquisitions and divestitures with less than a full year of
revenues in the comparative period.
2020 compared to 2019
Year over year movements in Revenues by Service Category and Segment were as
follows:
                                                                                                      Year Ended December 31,
                                                In millions                                                                                    Components of Change (%)
                                                                                                                               Organic
                                                                                                                                                                                       Foreign Exchange
                                2020               2019             Change ($)            Change (%)              Growth(1)             SOP Pricing             Divestitures                 (2)
Revenue by Service
Regulated Waste and
Compliance Services         $ 1,806.6          $ 2,187.8          $    (381.2)                 (17.4  %)               1.7  %                     -  %                 (18.4  %)               (0.7  %)
Secure Information
Destruction Services            745.3              901.9               (156.6)                 (17.4  %)             (15.8  %)                 (1.6) %                     -  %                 0.1  %
Communication and Related
Services                        123.6              219.2                (95.6)                 (43.6  %)              (6.1  %)                    -  %                 (37.5  %)                  -  %
Total Revenues              $ 2,675.5          $ 3,308.9          $    (633.4)                 (19.1  %)              (3.6  %)                 (0.4) %                 (14.6  %)               (0.5  %)
North America
Regulated Waste and
Compliance Services         $ 1,427.6          $ 1,762.8          $    (335.2)                 (19.0  %)               0.6  %                     -  %                 (19.5  %)                  -  %
Secure Information
Destruction Services            647.3              769.5               (122.2)                 (15.9  %)             (14.2  %)                 (1.6) %                     -  %                (0.1  %)
Communication and Related
Services                        114.3              207.6                (93.3)                 (44.9  %)              (6.9  %)                    -  %                 (38.0  %)                  -  %
Total North America Segment $ 2,189.2          $ 2,739.9          $    (550.7)                 (20.1  %)              (4.2  %)                 (0.4) %                 (15.5  %)                  -  %
International
Regulated Waste and
Compliance Services         $   379.0          $   425.0          $     (46.0)                 (10.8  %)               6.2  %                     -  %                 (13.4  %)               (3.6  %)
Secure Information
Destruction Services             98.0              132.4                (34.4)                 (26.0  %)             (24.9  %)                 (1.8) %                     -  %                 0.8  %
Communication and Related
Services                          9.3               11.6                 (2.3)                 (19.8  %)               8.6  %                     -  %                 (28.4  %)                  -  %

Total International Segment $ 486.3 $ 569.0 $ (82.7)

                 (14.5  %)              (1.0  %)                 (0.4) %                 (10.6  %)               (2.5  %)


(1)Growth is a change in revenues excluding the impact of SOP pricing,
divestitures and foreign exchange.
(2)The comparisons at constant currency rates (foreign exchange) reflect
comparative local currency balances at prior period's foreign exchange rates.
Stericycle calculated these percentages by taking current period reported
Revenues less the respective prior period reported Revenues, divided by the
prior period reported Revenues, all at the respective prior period's foreign
exchange rates. This measure provides information on the change in Revenues
assuming that foreign currency exchange rates have not changed between the prior
and the current period. Management believes the use of this measure aids in the
understanding of changes in Revenues without the impact of foreign currency.
2020 10-K Annual Report      Stericycle, Inc. • 44


--------------------------------------------------------------------------------

Table of Contents PART II




For the year ended December 31, 2020 as compared to the prior year, organic SID
and CRS revenues were lower, primarily reflecting COVID-19 pandemic-related
business disruption. Organic RWCS revenue was slightly favorable in the current
year in comparison to the prior year, primarily reflecting organic growth from
our quality of revenue initiatives and sustainable value-added services we
provide to customers. RWCS saw COVID-19 pandemic-related headwinds in the
maritime waste services business, along with the continued trend of patients
deferring elective surgeries. However, these negative trends were largely offset
by increased COVID-19 waste and mail-back volume along with our new pop-up
testing centers and non-health care PPE service.
North America revenues decreased $550.7 million, or 20.1%, for the year ended
December 31, 2020 to $2,189.2 million from $2,739.9 million for the year ended
December 31, 2019. Divestiture of the Environmental Solutions business in the
second quarter 2020 and divestiture of components of the CRS business sold in
the fourth quarter of 2019, reduced revenues by $423.4 million, or 15.5%.
Organic RWCS revenue was slightly favorable, 0.6%, in the current year in
comparison to the prior year, primarily reflecting organic growth from our
quality of revenue initiatives and sustainable value-added services we provide
to customers. RWCS saw COVID-19 pandemic-related headwinds in the maritime waste
services business, along with the continued trend of patients deferring elective
surgeries. However, these negative trends were largely offset by increased
COVID-19 waste and mail-back volume along with our new pop-up testing centers
and non-health care PPE service. SID organic revenue, excluding SOP pricing,
decreased $109.4 million or 14.2%, which is reflective of a reduction in service
stops. Additionally, there was a decrease in revenue due to the impact of SOP
pricing of $12.3 million, or 1.6% as compared to the prior year.
International revenues decreased $82.7 million, or 14.5%, for the year ended
December 31, 2020 to $486.3 million from $569.0 million for the year ended
December 31, 2019. The decrease in International segment organic revenue,
excluding SOP pricing, was $5.5 million, or 1.0%. Additionally, there was a
decrease in revenue due to the impact of SOP pricing of $2.4 million, or 1.8% as
compared to the prior year. International RWCS organic growth of 6.2% and CRS
growth of 8.6% was more than offset by a decline in SID of 24.9%. The majority
of International RWCS revenue growth is attributable to supporting our customers
through the COVID-19 pandemic while we estimate the underlying business had
slight growth being impacted by delayed elective surgeries. The decline in SID
was due to closures of non-essential businesses that lasted longer in
international locations than in the U.S. Divestiture components of the CRS
business sold in the fourth quarter of 2020, divestiture of Argentina operations
in the third quarter 2020, and the divestitures of the U.K. businesses, Chile
and Mexico operations in fiscal 2019 reduced revenues by $60.3 million, or
10.6%. The effect of foreign exchange rates unfavorably impacted International
revenues in 2020 by $14.5 million, or 2.5%, as foreign currencies, notably those
in Latin America, declined against the U.S. dollar.
2020 10-K Annual Report      Stericycle, Inc. • 45


--------------------------------------------------------------------------------


  Table of Contents         PART II


2019 compared to 2018
                                                                                                      Year Ended December 31,
                                               In millions                                                                                    

Components of Change (%)


                                                                                                                              Organic
                                                                                                                                                             Divestitures, net of        Foreign Exchange
                               2019               2018             Change ($)            Change (%)              Growth(1)             SOP Pricing               acquisitions                  (2)

Revenue by Service
Regulated Waste and
Compliance Services        $ 2,187.8          $ 2,261.8          $     (74.0)                  (3.3  %)               0.3  %                     -  %                     (0.9  %)               (2.7  %)
Secure Information
Destruction Services           901.9              911.0                 (9.1)                  (1.0  %)               3.6  %                  (4.6  %)                     0.9  %                (0.9  %)
Communication and Related
Services                       219.2              313.1                (93.9)                 (30.0  %)             (16.6  %)                    -  %                    (13.0  %)               (0.4  %)
Total Revenues             $ 3,308.9          $ 3,485.9          $    (177.0)                  (5.1  %)              (0.4  %)                 (1.2  %)                    (1.5  %)               (2.0  %)
North America
Regulated Waste and
Compliance Services        $ 1,762.8          $ 1,778.5          $     (15.7)                  (0.9  %)              (0.5  %)                    -  %                     (0.2  %)               (0.2  %)
Secure Information
Destruction Services           769.5              778.6                 (9.1)                  (1.2  %)               2.5  %                  (4.5  %)                     1.1  %                (0.3  %)
Communication and Related
Services                       207.6              286.0                (78.4)                 (27.4  %)             (18.0  %)                    -  %                     (9.2  %)               (0.2  %)
Total North America
Segment                    $ 2,739.9          $ 2,843.1          $    (103.2)                  (3.6  %)              (1.5  %)                 (1.2  %)                    (0.8  %)               (0.1  %)
International
Regulated Waste and
Compliance Services        $   425.0          $   483.3          $     (58.3)                 (12.1  %)               3.3  %                     -  %                     (3.7  %)              (11.7  %)
Secure Information
Destruction Services           132.4              132.4                    -                      -  %               10.1  %                  (5.1  %)                       -  %                (5.0  %)
Communication and Related
Services                        11.6               27.1                (15.5)                 (57.2  %)              (1.6  %)                    -  %                    (53.2  %)               (2.4  %)
Total International
Segment                    $   569.0          $   642.8          $     (73.8)                 (11.5  %)               4.5  %                  (1.0  %)                    (5.0  %)              (10.0  %)


(1)Growth is a change in revenues excluding the impact of SOP pricing,
divestitures and foreign exchange.
(2)The comparisons at constant currency rates (foreign exchange) reflect
comparative local currency balances at prior period's foreign exchange rates.
Stericycle calculated these percentages by taking current period reported
Revenues less the respective prior period reported Revenues, divided by the
prior period reported Revenues, all at the respective prior period's foreign
exchange rates. This measure provides information on the change in Revenues
assuming that foreign currency exchange rates have not changed between the prior
and the current period. Management believes the use of this measure aids in the
understanding of changes in Revenues without the impact of foreign currency.
Gross Profit
In millions
                                                                       Year Ended December 31,
                                                        2020                                             2019                               Change 2020 versus 2019
                                            $                  % of Revenue                  $                  % of Revenue                  $                   %
Gross profit                               1,053.1                      39.4  %             1,174.5                      35.5  %             (121.4)            (10.3  %)


The decrease in Gross profit for the year ended December 31, 2020, as compared
to 2019, was primarily due to the divestiture of the Environmental Solutions,
Argentina, and Expert Solutions businesses in 2020 and divestitures that
occurred during 2019, partially offset by quality of revenue initiatives. In
addition, gross profit was lower associated with the COVID-19 pandemic resulting
in decreased revenue discussed above specific to SID and CRS. These were
partially offset by reductions in variable and discretionary costs, driven by
operational efficiency improvements including in transportation and productivity
gains. Gross profit as a percentage of revenues has improved as divested
businesses historically produced lower margins as compared to core businesses
and operational efficiencies noted above. In addition, we continue to see lower
charges associated with our key priorities and other significant matters
discussed above.
International Gross profit as a percentage of revenues is lower than domestic
Gross profit as a percentage of Revenues because our international operations
have fewer small account customers, which tend to generate higher Gross profit
percentages. Our international operations generate most of their revenues from
large account
2020 10-K Annual Report      Stericycle, Inc. • 46

--------------------------------------------------------------------------------

Table of Contents PART II




customers, such as hospitals, publicly funded healthcare organizations and
government bodies. If our international revenues increase, consolidated Gross
profit percentages may experience downward pressure due to this "business mix"
shift, which may be offset by additional international small account market
penetration, operational optimization and domestic business expansion.
SG&A
In millions
                                                                          Year Ended December 31,
                                                        2020                                            2019                               Change 2020 versus 2019
                                            $                 % of Revenue                  $                  % of Revenue                  $                   %
SG&A                                        897.6                      33.5  %             1,055.1                      31.9  %             (157.5)            (14.9  %)


The decrease in SG&A for the year ended December 31, 2020, as compared to 2019,
was primarily due to disciplined spending on operations and the 2020
divestitures of the Environmental Solutions business, Argentina operations, and
components of the CRS business and other divestitures in 2019. Additionally, the
Company had lower employee costs due to the impact of furloughed team members,
lower commissions and reduced consulting and professional fees related to
divestitures, compliance and material weakness remediation costs. The decreases
referenced above were partially offset by higher incentive compensation.
Further, there was a decrease in intangible asset amortization as assets became
fully amortized. As a percentage of revenue, SG&A increased for the year ended
December 31, 2020 primarily due to higher incentive and stock based
compensation.
Divestitures losses (gains), net
In millions
                                                                            

Year Ended December 31,


                                                             2020                                           2019                             Change 2020 versus 2019
                                                 $                 % of Revenue                 $                 % of Revenue                 $                  %
Divestitures loss (gains), net                   123.6                       4.6  %             103.0                       3.1  %             20.6     

20.0 %




For additional information regarding Divestiture losses (gains), net, including
significant impacts of foreign currency translation adjustments, see Part II,
Item 8. Financial Statements and Supplementary Data; Note 4 - Restructuring,
Divestitures, and Impairments in the Consolidated Financial Statements.
Goodwill Impairment
In millions
                                                                            Year Ended December 31,
                                                           2020                                           2019                               Change 2020 versus 2019
                                               $                 % of Revenue                 $                 % of Revenue           $                     %
Goodwill impairment                                -                         -  %             228.3                       6.9  %             (228.3)            (100.0  %)


The Company performed its annual goodwill assessment as of October 1, 2020 and
determined no reporting units' carrying values were in excess of their estimated
fair value.
During 2019, as a result of our annual goodwill impairment and other periodic
assessments, we recognized non-cash goodwill impairment charges for our Canada,
Environmental Solutions, and Latin America reporting units of $126.6 million,
$80.8 million, and $20.9 million, respectively.
Segment Profitability
Beginning in the first quarter of 2020, we have changed our measure of segment
profitability to Adjusted Income from Operations - see Part II, Item 8.
Financial Statements and Supplementary Data; Note 18 - Segment Reporting in the
Consolidated Financial Statements for an explanation of this measure. Segment
profitability and a reconciliation of the total for segment profitability to
income (loss) from operations was as follows:
2020 10-K Annual Report      Stericycle, Inc. • 47


--------------------------------------------------------------------------------


  Table of Contents         PART II


In millions
                                                                              Year Ended December 31,
                                             2020                                       2019                                       2018                           Change 2020 versus 2019               Change 2019 versus 2018
                                                   % of Segment                               % of Segment                               % of Segment
                                   $                 Revenues                 $                 Revenues                 $                 Revenues                 $                  %                  $                   %
Adjusted Income from
Operations
North America                      606.0                  27.7  %             595.0                  21.7  %             754.4                  26.5  %             11.0              1.8  %             (159.4)           (21.1  %)
International                       46.5                   9.6  %              70.7                  12.4  %              64.7                  10.1  %            (24.2)           (34.2  %)               6.0              9.3  %
Other                             (263.9)                      nm            (213.7)                      nm            (200.1)                      nm            (50.2)            23.5  %              (13.6)             6.8  %
Total                              388.6                  14.5  %             452.0                  13.7  %             619.0                  17.8  %            (63.4)           (14.0  %)            (167.0)           (27.0  %)

Reconciliation to Income
(loss) from operations:
Adjusted Income from
Operations                         388.6                                      452.0                                      619.0
Adjusting Items Total(1)          (356.7)                                    (663.9)                                    (780.1)
Income (loss) from
Operations                          31.9                                     (211.9)                                    (161.1)


nm - percentage change not meaningful
(1) See Part II, Item 8. Financial Statements and Supplementary Data; Note 18 -
Segment Reporting
2020 compared to 2019
Adjusted Income from Operations for our North America segment increased $11.0
million, or 1.8%, for the year ended December 31, 2020 to $606.0 million from
$595.0 million for the year ended December 31, 2019. As a percentage of North
America revenues, Adjusted Income from Operations was 27.7% and 21.7%, for the
years ended December 31, 2020 and 2019, respectively. Adjusted Income from
Operations improved due to reductions in variable and discretionary costs,
driven by operational efficiency improvements including compensation,
transportation and disciplined spending in operations. The increase was
partially offset by 2020 divestitures of the Environmental Solutions business,
Argentina operations, and components of the CRS business and divestitures that
occurred during 2019. Operating margin improved as certain divested businesses
historically produced lower margins as compared to core businesses and
operational efficiencies noted above.
Adjusted Income from Operations for our International segment decreased $24.2
million, or 34.2%, for the year ended December 31, 2020 to $46.5 million from
$70.7 million for the year ended December 31, 2019. The decline was primarily a
reduction in income from operations due to the COVID-19 pandemic and the related
revenue decreases discussed above. As a percentage of International revenues,
Adjusted Income from Operations was 9.6% and 12.4% for the years ended
December 31, 2020 and 2019, respectively.
Adjusted Loss from Operations for Other increased in the year ended December 31,
2020 compared to the prior year as a result of higher incentive and stock-based
compensation, information technology and corporate insurance, partially offset
by lower worker's compensation expense.
Interest Expense, Net
In millions
                                                                          Year Ended December 31,
                                                         2020                                           2019                              Change 2020 versus 2019
                                             $                 % of Revenue                 $                 % of Revenue                 $                   %
Interest expense, net                         81.9                       3.1  %             118.3                       3.6  %             (36.4)            (30.8  %)


The decrease in the year ended December 31, 2020 as compared to 2019 is a result
of a lower weighted-average debt balance as well as lower interest rates. For
further information see Part II, Item 8. Financial Statements and Supplementary
Data; Note 9 - Debt.
Loss on Early Extinguishment of Debt
During 2019, we incurred a pre-tax loss on early extinguishment of debt of
$23.1 million, relating to the repayment of our private placement notes,
discussed in Capital Allocation above. We did not have any pre-tax loss on early
2020 10-K Annual Report      Stericycle, Inc. • 48


--------------------------------------------------------------------------------

Table of Contents PART II




extinguishment of debt in 2020. For further information see Part II, Item 8.
Financial Statements and Supplementary Data; Note 9 - Debt.
Other Expense, Net
In millions
                                                                      Year Ended December 31,
                                                         2020                                          2019                            Change 2020 versus 2019
                                             $                 % of Revenue                $                % of Revenue                 $                  %
Other expense, net                             6.0                       0.2  %             9.5                       0.3  %             (3.5)            (36.8  %)


Other expense, net is primarily comprised of foreign exchange losses including
the re-measurement of net monetary assets held in Argentina, prior to
divestiture in August 2020, as a result of its designation as a highly
inflationary economy.
Income Tax Benefit
In millions
                                                                          Year Ended December 31,
                                                         2020                                            2019                               Change 2020 versus 2019
                                            $                 Effective rate                 $                Effective rate                 $                   %
Income tax benefit                            0.1                         0.2  %             16.8                         4.6  %             (16.7)            (99.4  %)


Income tax benefit was $0.1 million in 2020 compared to income tax benefit of
$16.8 million in 2019. The effective tax rates for the years 2020 and 2019 were
0.2% and 4.6%, respectively. In 2020, our effective tax rate was negatively
impacted by valuation allowances and divestitures which was partially offset by
benefits from the CARES Act. In 2019, our effective tax rate was impacted by the
non-deductibility of a portion of the goodwill impairments in certain
jurisdictions, and valuation allowances recognized against net operating losses
in several countries.
For further information, see Part II, Item 8. Financial Statements and
Supplementary Data; Note 10 - Income Taxes in the Consolidated Financial
Statements.

Liquidity and Capital Resources
Details of our outstanding debt obligations can be found in Part II, Item 8.
Financial Statements and Supplementary Data; Note 9 - Debt in the Consolidated
Financial Statements.
The Company believes that it has sufficient liquidity to support its ongoing
operations and to invest in future growth to create value for its shareholders.
Operating cash flows and the Company's $1.20 billion Senior Credit Facility are
the Company's primary sources of liquidity and are expected to be used for,
among other things, payment of interest and principal on the Company's long-term
debt obligations, capital expenditures necessary to support growth and
productivity improvements, including those associated with shareholder
distributions approved by the Board of Directors. To the extent the Company
needs to add additional funding options to meet additional liquidity
requirements or diversify its funding portfolio, the Company could seek
additional financing from alternative sources, including approaching the capital
markets.
The Company generated positive impacts to cash flow from operations in 2020 as a
result of the CARES Act. The Company received $110.0 million, which was
comprised of $48.0 million in July 2020 and $62.0 million in December 2020, of
cash tax refunds for 2018 and 2019 U.S. net operating loss carryback claim,
respectively. A remaining carryback claims associated with the finalization of
the 2019 U.S. federal income tax return is currently filed with the IRS, and the
anticipated refund is less than $1.0 million. Additionally, starting in the
second quarter of 2020 and continued through the year ended December 31, 2020,
the Company deferred payments associated with employer related payroll taxes of
approximately $23.3 million under the CARES Act with expected payments in late
2021 and 2022.
Similar tax provisions and other stimulus measures have been granted either
before or after December 31, 2020 by certain foreign and U.S. state
jurisdictions which the Company continues to evaluate and apply, if
applicable. The Company has benefited in the year ended December 31, 2020 from
non-U.S. indirect tax payment deferrals of approximately $10.0 million, which
will be due in 2021.
2020 10-K Annual Report      Stericycle, Inc. • 49

--------------------------------------------------------------------------------

Table of Contents PART II




The Credit Agreement and Fifth Amendment contain a number of covenants,
including financial covenants. As of December 31, 2020, the Company was in
compliance with the Credit Agreement Debt Leverage Ratio covenant, with an
actual ratio of 3.54 to 1.00, which was below the allowed maximum ratio of 4.75
to 1.00 as contained in the Fifth Amendment. On April 6, 2020, the Company
completed the divestiture of its Environmental Solutions business. Therefore,
effective April 6, 2020, the Consolidated Leverage Ratio decreased by 0.25 to
4.75 to 1.00 for fiscal quarters ending on or before December 31, 2021 and 4.25
to 1.00 for fiscal quarters ending on or after March 31, 2022.
Given our current leverage position, we believe we should be able to operate
within our covenant thresholds, but due to the unpredictability of the COVID-19
pandemic and situations outside our control, it is reasonably likely that we
could exceed this Consolidated Leverage Ratio threshold at some point in the
next 12 months. This risk can be mitigated and potentially managed through
appropriate spending controls, divestitures, restructuring the Company's
existing indebtedness, amending the Credit Agreement, or seeking temporary
relief from the Consolidated Leverage Ratio covenant from the Company's lenders.
A failure to comply with these covenant provisions could result in an event of
default. Upon an event of default, unless waived, the lenders could elect to
terminate their commitments, cease making further loans and/or cause their loans
to become due and payable in full, foreclose against the assets securing the
debt under our Credit Agreement and force us and our subsidiaries into
bankruptcy or liquidation.
Working Capital
At December 31, 2020, our working capital decreased $94.3 million to a deficit
of $144.6 million compared to a deficit of $50.3 million at December 31, 2019.
This change is primarily driven by the divestiture of the Environmental
Solutions business in 2020.

Current assets decreased $154.1 million in 2020 to $552.5 million from $706.6
million in 2019 primarily driven by the divestitures of the Environmental
Solutions and Expert Solutions businesses. DSO was 52 days and 60 days as of
December 31, 2020 and 2019, respectively. When excluding the divestiture
revenues from the trailing 12-month DSO calculation, DSO was relatively
consistent at 56 and 55 days in 2020 and 2019, respectively.

Current liabilities decreased $59.8 million in 2020 to $697.1 million from
$756.9 million in 2019, primarily driven by the divestiture of the Environmental
Solutions business in 2020.
In millions
                                                                        Year Ended December 31,
                                                                        2020                 2019
Net cash from operating activities                                 $      530.2          $   248.0
Net cash from investing activities                                        381.4             (104.0)
Net cash from financing activities                                       (892.5)            (141.6)
Effect of exchange rate changes on cash and cash equivalents               (0.5)              (2.0)
Net change in cash and cash equivalents                            $       

18.6 $ 0.4




Operating Cash Flows: Net cash from operating activities increased $282.2
million in the year ended 2020 to $530.2 million from $248.0 million in 2019.
The current period primarily reflects (i) U.S. CARES Act net operating loss
carryback refund received in the third and fourth quarters of 2020 for a total
of $110.0 million , (ii) lower payments for legal and professional fees, annual
incentive compensation and prepaid software of $55.6 million compared to 2019,
(iii) government relief tax-related payment deferrals of $30.2 million in 2020,
roughly split two-thirds U.S. and one-third non-U.S., (iv) lower interest
payments of $26.0 million in 2020, (v) advances received on executed service
agreements of $19.2 million related to the Environmental Solutions divestiture
in the second quarter of 2020 and (vi) lower operating expenditures for ERP and
other related matters of approximately $20.0 million compared to 2019.
Investing Cash Flows: Net cash from investing activities increased $485.4
million in 2020 to net cash provided of $381.4 million from net cash used of
$104.0 million in 2019. Our capital expenditures decreased by $74.7 million to
$119.5 million from $194.2 million in 2019, primarily driven by the timing of
2019 investments in the ERP and 2020 disciplined capital management. In 2020, we
received $498.9 million in net proceeds from the divestiture of Expert
Solutions, operations in Argentina and Environmental Solutions businesses
compared to $86.6 million net divestiture proceeds in 2019.

2020 10-K Annual Report Stericycle, Inc. • 50

--------------------------------------------------------------------------------

Table of Contents PART II




Financing Cash Flows: Net cash from financing activities increased $750.9
million for the year ended 2020 to $892.5 million from $141.6 million in 2019.
The change related to our net repayments on our Senior Credit Facility and term
loan for $1,337.4 million principally due to the proceeds received from the new
debt issuance of Senior Notes, divestiture of the Environmental Solutions and
Expert Solutions businesses and higher net cash from operating activities
generated in 2020. Additionally, the Company made payments of other long-term
debt and foreign debt of $40.0 million in 2020. The decrease was partially
offset by proceeds of $500.0 million associated with debt issuance of the Senior
Notes in 2020. During 2019, net borrowings of $114.8 million included repayment
of private placement notes and $600.0 million new debt issuance of Senior Notes
and additional borrowings on the Senior Credit Facility and term loan. As a
result of the 2019 repayment of private placement notes, the Company paid $20.4
million for a make whole premium.
Contractual Obligations
The following table summarizes our significant contractual obligations and cash
commitments at December 31, 2020:
Payments due by period (in millions)
                                      Total              2021             2022-2023           2024-2025          2026 and After
Long term debt (1)                 $ 1,770.4          $   87.3          $    576.5          $    606.1          $        500.5
Finance lease liabilities               40.0               3.7                 7.7                 5.3                    23.3
Operating lease liabilities            435.9              86.2               151.5                97.6                   100.6
Estimated purchase obligations         114.4              60.5                51.9                 2.0                       -
Total contractual obligations and
cash commitments                   $ 2,360.7          $  237.7          $   

787.6 $ 711.0 $ 624.4

(1)These amounts represent the scheduled principal payments related to our long-term debt, excluding interest (see Part II, Item 8. Financial Statements and Supplementary Data; Note 9 - Debt in the Consolidated Financial Statements).



The Company establishes asset retirement obligations for the present value of
estimated future costs to retire long-lived assets at the termination or
expiration of a lease. Asset retirement obligations are not presented above but
the timing of such payments is not fixed and determinable (see Part II, Item 8.
Financial Statements and Supplementary Data; Note 12 - Commitments and
Contingencies in the Consolidated Financial Statements).
Payments for unrecognized tax benefits are excluded from contractual
obligations. Based on the uncertain nature of our liability for unrecognized tax
benefits, we are unable to make an estimate of the period of potential
settlement, if any, with the applicable taxing authorities.
As of December 31, 2020, we had $79.5 million of stand-by letters of credit
outstanding against our senior credit facility, $37.9 million of surety bonds
and $21.2 million of bank guarantees. The bank guarantees are issued mostly by
our international subsidiaries for various purposes, including leases, seller
notes, contracts and permits. The surety bonds are used for performance
guarantees. Neither the bank guarantees nor the surety bonds affect our ability
to use our various lines of credit.
We anticipate that our operating cash flows, together with additional borrowings
available under our Senior Credit Facility, as amended on February 25, 2020,
will be sufficient to meet our anticipated future operating expenses, key
priorities such as our new ERP implementation, capital expenditures and debt
service obligations as they become due during the next 12 months and the
foreseeable future.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations
are based upon our consolidated financial statements, which have been prepared
in accordance with U.S. GAAP. The preparation of these financial statements
requires management to make estimates, assumptions and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses and the related
disclosure of contingent assets and liabilities. Although management believes
that its estimates and assumptions are reasonable, they are based upon
information available when they are made and therefore, actual results may
differ from these estimates under different assumptions or conditions. Our most
critical accounting policies are those that may be material due to the levels of
subjectivity and judgment necessary to account for highly uncertain matters or
the susceptibility of such matters to change and those policies that have a
material impact on the financial condition or operating performance of the
Company. Part II, Item 8. Financial Statements and Supplementary Data; Note 1 -
Basis of Presentation and
2020 10-K Annual Report      Stericycle, Inc. • 51

--------------------------------------------------------------------------------

Table of Contents PART II




Summary of Significant Accounting Polices in the Consolidated Financial
Statements provides a detailed description of all of our material accounting
policies; however, we have identified the following as our most critical
accounting policies and estimates.
Revenue Recognition
Revenue is recognized when a customer obtains control of promised goods or
services. The amount of revenue recognized reflects the consideration to which
the Company expects to be entitled to receive in exchange for these good or
services. Revenue is recognized net of revenue-based taxes assessed by
governmental authorities.

The Company provides RWCS, which provide collection and processing of regulated
and specialized waste, including medical, pharmaceutical and hazardous waste,
for disposal and compliance programs; SID Services, which provide for the
collection of personal and confidential information for secure destruction and
recycling of shredded paper; and CRS which includes communication services such
as appointment reminders, secure messaging, event registration and other
communications for hospitals and IDN's. The associated activities for each of
these are a series of distinct services that are substantially the same and have
the same pattern of transfer over time; therefore, the respective services are
treated as a single performance obligation.

We recognize revenue by applying the right to invoice practical expedient as our
right to consideration corresponds directly to the value provided to the
customer for performance to date. Revenues for our regulated waste and secure
information destruction services are recognized upon waste collection. Our
compliance services are recognized over the contractual service period. Revenues
from communication services are recorded as the services are performed.
Allowance for Doubtful Accounts
The Company reports accounts receivable at their net realizable value, which is
management's best estimate of the cash that will ultimately be received. The
Company maintains an allowance for doubtful accounts to reflect the expected
uncollectability of accounts receivable based on historical collection data and
specific risks identified among uncollected accounts, as well as management's
expectation of future economic conditions. If current or expected future
economic trends, events, or changes in circumstances indicate that specific
receivable balances may be impaired, further consideration is given to the
collectability of those balances and the allowance is adjusted accordingly. The
adequacy of allowances for uncollectible accounts is reviewed at least quarterly
and adjusted as necessary based on such reviews. Management's judgment is
required to assess the collectability of an account, based on detailed analysis
of the aging of the receivables, the creditworthiness of the Company's
customers, historical collection trends, and current and future expected
economic trends.
Accounts receivable written off in subsequent periods can differ from the
allowance for doubtful accounts provided, but historically our provision has
been adequate. Allowance for doubtful accounts was $56.2 million and
$67.9 million as of December 31, 2020 and 2019, respectively.
Impairment of Long-Lived Assets
Property, Plant and Equipment and Intangible Assets (definite-lives), Net:
Long-lived assets, such as property, plant and equipment and amortizing
intangible assets are reviewed whenever events or changes in circumstances
indicate that the related carrying amounts may not be recoverable. Impairment of
assets with definite-lives is generally determined by comparing projected
undiscounted cash flows to be generated by the asset, or appropriate grouping of
assets, to its carrying value. If impairment is identified, a loss is recognized
equal to the excess of the asset's net book value over its fair value and the
cost basis is adjusted.
Determining the extent of impairment, if any, typically requires various
estimates and assumptions including using management's judgment, cash flows
directly attributable to the asset, the useful life of the asset and residual
value, if any. When necessary, the Company uses internal cash flow estimates,
quoted market prices and appraisals as appropriate to determine fair
value. Actual results could vary from these estimates. In addition, the
remaining useful life of the impaired asset is revised, if necessary.
(For additional information, see Part II, Item 8. Financial Statements and
Supplementary Data; Note 5 - Property, Plant and Equipment and Note 7 - Goodwill
and Other Intangible Assets in the Consolidated Financial Statements).
2020 10-K Annual Report      Stericycle, Inc. • 52


--------------------------------------------------------------------------------

Table of Contents PART II




Intangible Assets (indefinite-lived): Indefinite-lived intangibles consist
primarily of permits and tradenames. Indefinite-lived intangibles are assessed
for impairment annually, as of October 1, or more frequently if an event occurs
or circumstances change and are not subject to amortization but are assessed for
impairment in the same manner as goodwill. Indefinite lived intangibles may be
assessed using either a qualitative or quantitative approach.  The qualitative
approach first determines if it is more-likely-than-not that the fair value of
the asset is less than the carrying value.  If no such determination is made,
then the impairment test is complete.  If, however, it is determined that there
is a likely impairment, a quantitative assessment is performed.  In the fourth
quarter of 2020, we performed our annual impairment test on indefinite-lived
intangibles, other than goodwill, using the qualitative approach for certain
assets and the quantitative approach for the remaining assets. The calculated
fair value of our indefinite-lived intangibles is based upon, among other
things, certain assumptions about expected future operating performance,
internal and external processing costs and an appropriate discount rate
determined by management.
Future changes in our assumptions or the interrelationship of the assumptions
described above may negatively impact future valuations that would require
non-cash charges and may have a material effect on our financial condition and
operating results.
Goodwill: Goodwill is assessed for impairment annually as of October 1 of each
year, or more frequently if an event occurs or circumstances change that could
reduce the value of a reporting until below its carrying value.
We used a quantitative approach to assess goodwill for impairment. The fair
value of each reporting unit is calculated using the income approach (including
DCF) and validated using a market approach with the involvement of a third-party
valuation specialist. Our reporting units are: Domestic RWCS, Domestic SID,
Domestic CRS, Canada, Europe, Asia Pacific and Latin America. The income
approach uses expected future cash flows of each reporting unit and discounts
those cash flows to present value.  Expected future cash flows are calculated
using management assumptions of growth rates, including long-term growth rates,
capital expenditures and cost efficiencies.  Future acquisitions or divestitures
are not included in the expected future cash flows. We use a discount rate based
on a calculated weighted average cost of capital which is adjusted for each of
our reporting units based on size, country and company specific risk premiums.
The market approach compares the valuation multiples of similar companies to
that of the associated reporting unit.  In addition, we analyze differences
between the sum of the fair value of the reporting units and our total market
capitalization for reasonableness, taking into account certain factors including
control premiums.
The fair value is then compared to its carrying value including goodwill. If the
fair value is in excess of its carrying value, the related goodwill is not
impaired. If the fair value is less than its carrying value, we recognize an
impairment charge in the amount that the carrying value exceeds the fair value
but not to exceed the carrying value of any goodwill.
We performed our annual goodwill assessment as of October 1, 2020. As a result
of this assessment, no goodwill impairment charges were recognized in 2020. For
additional information, see Part II, Item 8. Financial Statements and
Supplementary Data; Note 7 - Goodwill and Other Intangible Assets in the
Consolidated Financial Statements.
A measure of sensitivity of the amount of goodwill impairment charges to key
assumptions is the amount by which each reporting unit's fair value exceeds
their respective carrying value. As of the October 1, 2020 assessment, the
estimated fair value of each reporting unit exceeded its carrying value by at
least 20%. We performed sensitivity analysis on our estimated fair values,
noting that a 50 basis point increase in the discount rate or a 50 basis point
reduction in the long-term growth rate would not result in impairments for any
of our reporting units.
Intangible Assets Lives
We have determined that certain of our operating permits and certain tradenames
have indefinite lives due to our ability to renew them with minimal additional
cost and therefore they are not amortized.
Our finite-lived intangible assets are amortized over their useful lives using
the straight-line method. Our customer relationships have useful lives from 10
to 25 years based upon the type of customer. We have non-compete covenant
intangibles with useful lives of 5 years. We also have tradename intangibles
with useful lives from 15 to 40 years.
We evaluate the useful life of our intangible assets annually to determine
whether events and circumstances warrant a revision to their remaining useful
life and changes are reflected prospectively as the intangible asset is
2020 10-K Annual Report      Stericycle, Inc. • 53


--------------------------------------------------------------------------------

Table of Contents PART II




amortized over the revised remaining useful life.  In the fourth quarter of
2020, we performed the annual assessment of the useful life of our finite-lived
intangibles and made no changes to useful lives.
Assets and Liabilities Held-for-Sale
We classify Long-lived assets or disposal groups as held-for-sale when
management having the appropriate authority, generally our Board of Directors or
certain of our Executive Officers, commits to a plan of sale, the disposal group
is ready for immediate sale, an active program to locate a buyer has been
initiated and the sale is probable and expected to be completed within one
year. Once classified as held-for-sale disposal groups are valued at the lower
of their carrying amount or fair value less estimated selling costs. Where the
disposal group constitutes substantially all, generally more than 90% of the
assets and liabilities of our operations in a foreign country, the balance in
the cumulative currency translation adjustment associated with that country is
included in the carrying value of the disposal group. If the carrying value,
including any amount associated with the cumulative currency translation,
adjustment exceeds the fair value less estimated selling costs a held-for-sale
impairment charge is recorded to reduce the carrying value.
The estimate for fair value is reviewed at the end of every reporting period
that the disposal group is classified as held-for-sale and the carrying value
adjusted whenever the estimated fair value less costs to sell is less than the
carrying value.
Contingencies and Litigation
We are subject to various legal proceedings, claims and regulatory matters, the
outcomes of which are subject to significant uncertainty. We determine whether
to disclose or accrue for loss contingencies based on an assessment of whether
the risk of loss is remote, reasonably possible or probable, and whether it can
be reasonably estimated. We analyze our litigation and regulatory matters based
on available information to assess the potential liabilities. Management's
assessment is developed based on an analysis of possible outcomes under various
strategies. We record and disclose loss contingencies pursuant to the applicable
accounting guidance for such matters (For additional information, see Part II,
Item 8. Financial Statements and Supplementary Data; Note 20 - Legal Proceedings
in the Consolidated Financial Statements).
Income Taxes
We record a provision for income taxes for the anticipated tax consequences of
our reported results of operations using the asset and liability method.
Deferred income taxes are recognized by applying enacted statutory tax rates
applicable to future years to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax
basis as well as net operating loss and tax credit carryforwards. The effect on
deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that includes the enactment date. The measurement of
deferred tax assets is reduced, if necessary, by a valuation allowance for any
tax benefits for which future realization is uncertain.
Although we believe our assumptions, judgments and estimates are reasonable,
changes in tax laws or our interpretation of tax laws and the resolution of any
tax audits could significantly impact the amounts provided for income taxes in
our Consolidated Financial Statements.
In evaluating our ability to recover our deferred tax assets, in full or in
part, we consider all available positive and negative evidence, including our
past operating results, and our forecast of future earnings, future taxable
income and prudent and feasible tax planning strategies. The assumptions
utilized in determining future taxable income require significant judgment and
are consistent with the plans and estimates we are using to manage the
underlying businesses. Actual operating results in future years could differ
from our current assumptions, judgments and estimates. However, we believe that
it is more likely than not that most of the deferred tax assets recognized on
our Consolidated Balance Sheets will ultimately be realized. We record a
valuation allowance to reduce our deferred tax assets to the net amount that we
believe is more likely than not to be realized.
We did not recognize certain tax benefits from uncertain tax positions within
the provision for income taxes. We may recognize a tax benefit only if it is
more likely than not the tax position will be sustained on examination by the
taxing authorities, based on the technical merits of the position. The tax
benefits recognized in the financial statements from such positions are then
measured based on the largest benefit that has a greater than 50% likelihood of
being realized upon settlement.  At December 31, 2020, our estimated gross
unrecognized tax benefits were $24.3 million, of which $23.2 million, if
recognized, would favorably impact our future earnings. Due to uncertainties in
any tax audit outcome, our estimates of the ultimate settlement of our
unrecognized tax positions may change and the actual tax benefits may differ
significantly from the estimates.
2020 10-K Annual Report      Stericycle, Inc. • 54


--------------------------------------------------------------------------------

Table of Contents PART II




The Tax Act established GILTI provisions that impose a tax on foreign income in
excess of a deemed return on intangible assets of foreign corporations. We
recognize the taxes on GILTI as a period expense rather than to recognize
deferred taxes for basis differences that are expected to affect the amount of
GILTI inclusion upon reversal.
For further information see Part II, Item 8. Financial Statements and
Supplementary Data; Note 10 - Income Taxes in the Consolidated Financial
Statements.
Insured and Self-Insured Claims
The Company's insurance for workers' compensation, auto/fleet, general
liability, property and employee-related health care benefits is obtained using
high deductible insurance policies, if any, meaning that the Company has
retained a significant portion of the risks related to the claims associated
with these programs. The estimated exposure for unpaid claims and associated
expenses, including incurred but not reported losses, is based on a calculation
performed by a third-party actuarial specialist using the Company's historical
claims experience. The accruals for these liabilities could be revised if future
occurrences or loss developments significantly differ from the assumptions
used. Estimated recoveries associated with insured claims are recognized as
assets when the receipt of such amounts is probable.
Stock-Based Compensation
We measure the cost of employee services received in exchange for an award of
equity instruments based on the grant-date fair value of the award. That cost is
recognized over the period during which an employee is required to provide
service in exchange for the award-the requisite service period, usually the
vesting period. Performance based awards are recognized consistent with
performance metrics and Accounting Standards Codification Section 718
Compensation - Stock Compensation. No compensation cost is recognized for equity
instruments for which employees do not render the requisite service.
We use the Black-Scholes valuation model and the Monte Carlo simulation model to
determine the fair value of stock options and PSU's, respectively, once the
related performance criteria have been established. The fair value models
include various assumptions, including the expected volatility and expected life
of the awards. Given the considerable judgment involved in these assumptions and
complex modeling, we typically obtain assistance from third-party valuation
specialists. The fair value of RSU's is determined based on closing price of our
common stock on the date of grant. If an equity award is modified after the
grant date, we assess the impact of the modification and where necessary record
compensation cost calculated as any incremental fair value of the modified award
over the fair value of the original award immediately before the modification.
For further detail, see Part II, Item 8. Financial Statements and Supplementary
Data; Note 14 - Stock Based Compensation in the Consolidated Financial
Statements.
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
In the normal course of business, we are exposed to market risks, including
changes in interest rates, certain commodity prices, including SOP and diesel
fuel and foreign currency rates. We do not specifically hedge our exposure to
these risks.

We are subject to market risks arising from changes in interest rates which
relate primarily to our financing activities. We performed a sensitivity
analysis to determine how market rate changes might affect the fair value of our
market risk-sensitive debt instruments. Our potential additional interest
expense over one year that would result from a hypothetical, instantaneous and
unfavorable change of 100 basis points in the interest rate on all of our
variable rate obligations would be approximately $6.3 million on a pre-tax
basis.

We have exposure to foreign currency fluctuations. We have subsidiaries in 17
foreign countries whose revenues and expenses are denominated in local currency
and who use local currency denominated lines of credit for their funding
needs. We translate results of operations of our international operations using
an average exchange rate. We have quantified and described the impact of foreign
currency translation on our revenues. We estimate, that based upon the amounts
reported by individual countries during the year ended December 31, 2020 and
prevailing exchange rates at that date, a 1% devaluation of all the functional
currencies of each of our foreign businesses would result in an approximate
$1.9 million increase to the Net loss attributable to Stericycle, Inc. reported
in our Consolidated Statements of Loss.

2020 10-K Annual Report Stericycle, Inc. • 55

--------------------------------------------------------------------------------

Table of Contents PART II




We have cumulative currency translation adjustment losses as of December 31,
2020 of approximately $187.4 million which are subject to continued fluctuations
due to changes in foreign currency rates. In addition, to the extent that we
sell substantially all of the operations within one country, similar to the
transactions undertaken in Argentina during 2020 and Mexico and Chile during
2019, we would be required to recognize, in the Statements of Loss, the
accumulated currency translation losses or gains associated with that country.

The U.K.'s Financial Conduct Authority, which regulates LIBOR, announced in 2017
that it intends to phase out LIBOR by the end of 2021. The Company's contracts
with respect to its borrowings already contain comparable alternative reference
rates that would automatically take effect upon the phasing out of LIBOR.
Item 8. Financial Statements and Supplementary Data
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Stericycle, Inc.


Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Stericycle, Inc.
(the Company) as of December 31, 2020 and 2019, the related consolidated
statements of loss, comprehensive income (loss), changes in equity and cash
flows for each of the three years in the period ended December 31, 2020, and the
related notes and financial statement schedule listed in the Index at Item 15(a)
(collectively referred to as the "consolidated financial statements"). In our
opinion, the consolidated financial statements present fairly, in all material
respects, the financial position of the Company at December 31, 2020 and 2019,
and the results of its operations and its cash flows for each of the three years
in the period ended December 31, 2020, in conformity with U.S. generally
accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), the Company's internal
control over financial reporting as of December 31, 2020, based on criteria
established in Internal Control - Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (2013 framework) and our
report dated February 25, 2021 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement, whether due to error or fraud. Our audits included performing
procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud and performing procedures that respond
to those risks. Such procedures include examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits
also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of
the financial statements. We believe that our audits provide a reasonable basis
for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the
current period audit of the consolidated financial statements that was
communicated or required to be communicated to the audit committee and that: (1)
relates to accounts or disclosures that are material to the consolidated
financial statements and (2) involved our especially challenging, subjective or
complex judgments. The communication of the critical audit matter does not alter
in any way our opinion on the consolidated financial statements, taken as a
whole, and we are not, by communicating the critical audit matter below,
providing separate opinions on the critical audit matter or on the account or
disclosure to which it relates.
2020 10-K Annual Report      Stericycle, Inc. • 56


--------------------------------------------------------------------------------


  Table of Contents         PART II


                            Valuation of Goodwill

Description of the Matter   At December 31, 2020, the Company's goodwill was $2,819.3 million. As
                            disclosed in Note 7 to the consolidated

financial statements, goodwill


                            is tested for impairment at the reporting unit level annually as of
                            October 1, or more frequently, if a triggering event occurs. The
                            Company determined no reporting unit's carrying value was in excess of
                            its respective fair value.
                            Auditing management's goodwill impairment assessment was complex and
                            highly judgmental due to the significant estimation required in
                            determining the fair value of the Company's reporting units. In
                            particular, the fair value estimates were sensitive to significant
                            assumptions, such as discount rates,

projections of revenue, cost of


                            revenue and operating expense growth rates, and long-term growth rates
                            which are affected by expectations about future market or economic
                            conditions, particularly those in markets with challenging economic
                            conditions.

How We Addressed the Matter We obtained an understanding, evaluated the design, and tested the
in                          operating effectiveness of controls over the Company's goodwill
Our Audit                   impairment review process. For example, we tested controls over
                            management's review of the significant

assumptions discussed above


                            used to develop the fair value estimates. We also tested management's
                            controls over the completeness and accuracy of the underlying data
                            used in the valuation.
                            To test the estimated fair value of the

Company's reporting units, we


                            performed audit procedures that included, among 

others, assessing


                            methodologies and testing the significant 

assumptions discussed above


                            and the underlying data used by the Company in its analysis. We
                            involved our valuation specialists to review the Company's model,
                            methods, and the more sensitive assumptions utilized such as the
                            discount rate and long-term growth assumptions. We compared the
                            significant assumptions used by management to current industry and
                            economic trends, changes to the Company's business model, customer
                            base and other relevant factors. We assessed the historical accuracy
                            of management's estimates and performed sensitivity analyses of
                            significant assumptions to evaluate the changes in the fair value of
                            the reporting units that would result from

changes in the assumptions.


                            We reconciled the fair value of the reporting units to their carrying
                            values, testing the Company's determination of the assets and
                            liabilities used within the reporting units

that are the basis for the


                            carrying values. In addition, we tested 

management's reconciliation of


                            the fair value of all the reporting units to the market capitalization
                            of the Company and assessed the adequacy of the Company's goodwill
                            valuation disclosures.


/s/ Ernst & Young LLP
We have served as the Company's auditor since 1991.
Chicago, Illinois
February 25, 2021
2020 10-K Annual Report      Stericycle, Inc. • 57

--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                        CONSOLIDATED STATEMENTS OF LOSS

In millions, except per share data


                                                                       Year 

Ended December 31,


                                                              2020               2019               2018
Revenues                                                  $ 2,675.5          $ 3,308.9          $ 3,485.9
Cost of revenues                                            1,622.4            2,134.4            2,109.9
Gross profit                                                1,053.1            1,174.5            1,376.0
Selling, general and administrative expenses                  897.6            1,055.1            1,165.6
Goodwill impairment                                               -              228.3              358.7
Divestiture losses (gains), net                               123.6              103.0               12.8
Income (loss) from operations                                  31.9             (211.9)            (161.1)
Interest expense, net                                         (81.9)            (118.3)            (106.0)
Loss on early extinguishment of debt                              -              (23.1)                 -
Other expense, net                                             (6.0)              (9.5)              (8.3)
Loss before income taxes                                      (56.0)            (362.8)            (275.4)
Income tax benefit                                              0.1               16.8               29.8
Net loss                                                      (55.9)            (346.0)            (245.6)
Net (income) loss attributable to noncontrolling
interests                                                      (1.4)              (0.8)               0.9
Net loss attributable to Stericycle, Inc.                     (57.3)            (346.8)            (244.7)
Mandatory convertible preferred stock dividend                    -                  -              (25.5)
Gain on repurchase of preferred stock                             -                  -               16.9
Net loss attributable to Stericycle, Inc. common
shareholders                                              $   (57.3)         $  (346.8)         $  (253.3)
Loss per common share attributable to Stericycle, Inc.
common shareholders:
Basic                                                     $   (0.63)         $   (3.81)         $   (2.91)
Diluted                                                   $   (0.63)         $   (3.81)         $   (2.91)
Weighted average number of common shares
Outstanding:
Basic                                                          91.5               91.0               87.1
Diluted                                                        91.5               91.0               87.1

See accompanying Notes to Consolidated Financial Statements. 2020 10-K Annual Report Stericycle, Inc. • 58

--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                    CONSOLIDATED STATEMENTS OF COMPREHENSIVE
                                 INCOME (LOSS)
In millions
                                                                      Year Ended December 31,
                                                             2020              2019              2018
Net loss                                                  $  (55.9)         $ (346.0)         $ (245.6)

Other comprehensive income (loss):
Currency translation adjustments                              44.0               8.8             (80.3)

Cumulative currency translation loss realized through disposition of Argentina operations

                           87.2                 -                 -

Cumulative currency translation loss realized through disposition of Mexico operations

                                 -              18.9                 -

Cumulative currency translation loss realized through disposition of Chile operations

                                  -              16.8                 -

Amortization of cash flow hedge into income, net of tax expense ($0.2 and $0.4 for the years ended December 31, 2019 and 2018, respectively)

                                     -               0.4               1.0

Change in fair value of cash flow hedge, net of tax expense ($0.1 for the year ended December 31, 2019)

              -               0.3                 -

Accelerated amortization of interest rate lock premiums, net of tax expense ($1.1 for the year ended December 31, 2019)

                                                            -               2.3                 -
Total other comprehensive income (loss)                      131.2              47.5             (79.3)

Comprehensive income (loss)                                   75.3            (298.5)           (324.9)
Less: comprehensive income (loss) attributable to
noncontrolling interests                                       1.9               1.1              (1.9)

Comprehensive income (loss) attributable to Stericycle, Inc. common shareholders

$   73.4

$ (299.6) $ (323.0)

See accompanying Notes to Consolidated Financial Statements. 2020 10-K Annual Report Stericycle, Inc. • 59


--------------------------------------------------------------------------------

                                STERICYCLE, INC.
                          CONSOLIDATED BALANCE SHEETS

In millions, except per share data


                                                                              December 31,
                                                                         2020               2019
ASSETS
Current Assets:
Cash and cash equivalents                                            $    53.3          $    34.7
Accounts receivable, less allowance for doubtful accounts of $56.2
in 2020 and $67.9 in 2019                                                380.7              544.3
Prepaid expenses                                                          63.0               60.7
Other current assets                                                      55.5               66.9
Total Current Assets                                                     552.5              706.6

Property, plant and equipment, less accumulated depreciation of $629.7 in 2020 and $667.8 in 2019

                                        701.3              798.5
Operating lease right-of-use assets                                      365.0              435.0
Goodwill                                                               2,819.3            2,982.2
Intangible assets, less accumulated amortization of $641.6 in 2020
and $584.9 in 2019                                                     1,087.4            1,422.4
Other assets                                                              56.4               92.3
Total Assets                                                         $ 5,581.9          $ 6,437.0
LIABILITIES AND EQUITY
Current Liabilities:
Current portion of long-term debt                                    $    91.0          $   103.1
Bank overdraft                                                               -                1.9
Accounts payable                                                         181.2              220.1
Accrued liabilities                                                      289.4              296.6
Operating lease liabilities                                               86.2               94.8
Other current liabilities                                                 49.3               40.4
Total Current Liabilities                                                697.1              756.9
Long-term debt, net                                                    1,689.1            2,559.3
Long-term operating lease liabilities                                    299.0              356.1
Deferred income taxes                                                    380.4              295.1
Long-term tax payable                                                     22.7               70.7
Other liabilities                                                         59.2               64.2
Total Liabilities                                                      3,147.5            4,102.3

Commitments and contingencies

Equity:

Preferred stock (par value $0.01 per share, 1.0 shares authorized), mandatory convertible preferred stock, Series A, none issued and outstanding in 2020 and 2019

                                                 -                  -
Common stock (par value $0.01 per share, 120.0 shares authorized,
91.6 and 91.2 issued and outstanding in 2020 and 2019, respectively)       0.9                0.9
Additional paid-in capital                                             1,234.0            1,205.7
Retained earnings                                                      1,382.6            1,442.4
Accumulated other comprehensive loss                                    (187.4)            (318.1)
Total Stericycle, Inc.'s Equity                                        2,430.1            2,330.9
Noncontrolling interests                                                   4.3                3.8
Total Equity                                                           2,434.4            2,334.7
Total Liabilities and Equity                                         $ 5,581.9          $ 6,437.0

See accompanying Notes to Consolidated Financial Statements. 2020 10-K Annual Report Stericycle, Inc. • 60

--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
In millions
                                                                       Year Ended December 31,
                                                             2020                2019               2018
OPERATING ACTIVITIES:
Net loss                                                 $    (55.9)         $  (346.0)         $  (245.6)
Adjustments to reconcile net loss to net cash from
operating activities:
Depreciation                                                  108.6              127.6              125.6
Intangible amortization                                       124.9              145.2              130.3

Loss on early extinguishment of debt and related charges -

       26.5                  -
Stock-based compensation expense                               25.5               17.1               24.1
Deferred income taxes                                          32.6              (33.9)             (34.1)
Goodwill impairment                                               -              228.3              358.7
Divestiture losses, net of gains                              123.6              103.0               12.8

Asset impairments, gain/loss on disposal of property plant and equipment and other charges

                          18.3               28.1               47.4
Other, net                                                      5.1                2.5                3.8
Changes in operating assets and liabilities, net of the
effects of acquisitions and divestitures:
Accounts receivable                                            27.4               24.5                3.6
Prepaid expenses                                               68.9              (18.4)             (15.6)
Accounts payable                                               (5.5)              (4.6)               9.3
Accrued liabilities                                             8.2              (33.4)            (238.5)
Other assets and liabilities                                   48.5              (18.5)             (16.1)
Net cash from operating activities                            530.2              248.0              165.7
INVESTING ACTIVITIES:
Capital expenditures                                         (119.5)            (194.2)            (130.8)
Payments for acquisitions, net of cash acquired                   -               (0.2)             (44.7)
Proceeds from divestitures of businesses                      498.9               86.6               25.2
Other, net                                                      2.0                3.8                2.8
Net cash from investing activities                            381.4             (104.0)            (147.5)
FINANCING ACTIVITIES:
Repayments of long-term debt and other obligations            (31.1)             (50.4)             (64.5)
Proceeds from foreign bank debt                                 1.8               12.1               12.1
Repayment of foreign bank debt                                (10.7)             (47.8)             (17.8)
Proceeds from term loan                                           -              365.0                  -
Repayment of term loan                                       (749.7)             (95.3)             (47.5)
Repayment of private placement of long-term note                  -           (1,075.0)                 -
Proceeds from senior debt                                     500.0              600.0                  -
Proceeds from senior credit facility                        1,210.6            1,752.2            1,657.2
Repayment of senior credit facility                        (1,798.3)          (1,575.6)          (1,541.0)
Repayment of bank overdrafts, net                              (1.7)             (12.5)               8.7
Payments of capital lease obligations                          (4.3)              (4.3)              (8.2)
Payments of debt issuance costs                                (7.3)              (8.8)              (1.7)

Proceeds from issuance of common stock, net of (payments of) taxes from withheld shares

                                 (0.4)              19.9               20.1
Payments on early debt extinguishment                             -              (20.4)                 -
Payments for repurchase of mandatory convertible
preferred stock                                                   -                  -              (17.2)
Dividends paid on mandatory convertible preferred stock           -                  -              (25.5)
Payments to noncontrolling interests                           (1.4)              (0.7)              (0.4)
Net cash from financing activities                           (892.5)            (141.6)             (25.7)
Effect of exchange rate changes on cash and cash
equivalents                                                    (0.5)              (2.0)              (0.4)
Net change in cash and cash equivalents                        18.6                0.4               (7.9)
Cash and cash equivalents at beginning of year                 34.7               34.3               42.2
Cash and cash equivalents at end of year                 $     53.3

$ 34.7 $ 34.3



SUPPLEMENTAL CASH FLOW INFORMATION:
Net issuances of obligations for acquisitions            $        -          $     0.3          $    30.1
Capital expenditures in accounts payable                 $     11.7          $    33.8          $    30.8
Interest paid during the year, net of capitalized
interest                                                 $     75.5          $   101.5          $    93.7
Income taxes (refunded) paid during the year, net        $    (83.7)

$ 6.9 $ 26.4

See accompanying Notes to Consolidated Financial Statements. 2020 10-K Annual Report Stericycle, Inc. • 61

--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                  CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
In millions
                                                                                        Stericycle, Inc. Equity
                                                                                                           Additional
                                                                                                            Paid-In             Retained           Accumulated Other           Noncontrolling
                                        Preferred Stock                      Common Stock                   Capital             Earnings           Comprehensive Loss             Interests              Total Equity
                                     Shares           Amount            Shares            Amount
Balance as of January 1, 2018           0.7          $    -                85.5          $  0.9          $   1,153.2          $  2,029.5          $          (287.0)         $           12.0          $     2,908.6
Cumulative effect of new
accounting standard                       -               -                   -               -                    -                13.0                          -                         -                   13.0
Net loss                                  -               -                   -               -                    -              (244.7)                         -                      (0.9)                (245.6)
Currency translation adjustment           -               -                   -               -                    -                   -                      (79.3)                     (1.0)                 (80.3)
Change in qualifying cash flow
hedge, net of tax                         -               -                   -               -                    -                   -                        1.0                         -                    1.0
Issuance of common stock for
exercise of options, PSU and RSU
vesting and employee stock
purchases, net                            -               -                 0.5               -                 19.4                   -                          -                         -                   19.4
Repurchase and cancellation of
convertible preferred stock            (0.1)              -                   -               -                (34.1)               16.9                          -                         -                  (17.2)
Conversion of convertible
preferred stock to common stock        (0.6)              -                 4.7               -                    -                   -                          -                         -                      -
Preferred stock dividend                  -               -                   -               -                    -               (25.5)                         -                         -                  (25.5)
Stock compensation expense                -               -                   -               -                 24.1                   -                          -                         -                   24.1
Changes to noncontrolling
interest                                  -               -                   -               -                    -                   -                          -                      (0.4)                  (0.4)
Balance as of December 31, 2018           -               -                90.7             0.9              1,162.6             1,789.2                     (365.3)                      9.7                2,597.1
Net loss                                  -               -                   -               -                    -              (346.8)                         -                       0.8                 (346.0)
Currency translation adjustment           -               -                   -               -                    -                   -                        8.5                       0.3                    8.8
Change in qualifying cash flow
hedge, net of tax                         -               -                   -               -                    -                   -                        0.7                         -                    0.7
Accelerated amortization of
interest rate lock premiums, net
of tax                                    -               -                   -               -                    -                   -                        2.3                         -                    2.3
Issuance of common stock for
exercise of options, PSU and RSU
vesting and employee stock
purchases, net                            -               -                 0.5               -                 19.7                   -                          -                         -                   19.7
Cumulative currency translation
loss realized through disposition
of Mexico operations                      -               -                   -               -                    -                   -                       18.9                         -                   18.9
Cumulative currency translation
loss realized through disposition
of Chile operations                       -               -                   -               -                    -                   -                       16.8                         -                   16.8
Stock compensation expense                -               -                   -               -                 17.1                   -                          -                         -                   17.1
Changes to noncontrolling
interest                                  -               -                   -               -                  6.3                   -                          -                      (7.0)                  (0.7)
Balance as of December 31, 2019           -               -                91.2             0.9              1,205.7             1,442.4                     (318.1)                      3.8                2,334.7
Net loss                                  -               -                   -               -                    -               (57.3)                                                 1.4                  (55.9)
Currency translation adjustment           -               -                   -               -                    -                   -                       43.5                       0.5                   44.0

Issuance of common stock for
exercise of options, PSU and RSU
vesting and employee stock
purchases, net                            -               -                 0.4               -                  2.8                   -                          -                         -                    2.8
Cumulative currency translation
loss realized through disposition
of Argentina operations                   -               -                   -               -                    -                   -                       87.2                         -                   87.2
Stock compensation expense                -               -                   -               -                 25.5                   -                          -                         -                   25.5
Change in accounting principle            -               -                   -               -                    -                (2.5)                         -                         -                   (2.5)
Changes to noncontrolling
interest                                  -               -                   -               -                    -                   -                          -                      (1.4)                  (1.4)
Balance as of December 31, 2020           -          $    -                

91.6 $ 0.9 $ 1,234.0 $ 1,382.6 $

       (187.4)         $            4.3          $     2,434.4

See accompanying Notes to Consolidated Financial Statements. 2020 10-K Annual Report Stericycle, Inc. • 62

--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      (In millions, except per share data and unless otherwise indicated)
Unless the context requires otherwise, "Company", "Stericycle", "we", "us", or
"our" refers to Stericycle, Inc. and its subsidiaries on a consolidated basis.
NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Description of Business
Incorporated in 1989, Stericycle protects people, safeguards communities and
reduces risk through highly specialized waste management and secure information
destruction services. The Company serves customers in the U.S. and 17 other
countries with a concentration on the growing healthcare industry.
The Company's core business focus is on regulated waste and compliance services
and secure information destruction, and it is the leading provider of these
services in terms of both revenue and operational infrastructure.
For further information on the Company's business, segments and services, see
Note 18 - Segment Reporting.
Summary of Significant Accounting Policies
Basis of Presentation: The accompanying consolidated financial statements
include the accounts of Stericycle, Inc. and its subsidiaries. All intercompany
accounts and transactions have been eliminated in consolidation. The Company's
consolidated financial statements were prepared in accordance with U.S. GAAP and
include the assets, liabilities, revenue and expenses of all wholly-owned
subsidiaries and majority-owned subsidiaries over which the Company exercises
control. Outside stockholders' interests in subsidiaries are shown on the
consolidated financial statements as "Noncontrolling interests."

Use of Estimates: The preparation of financial statements in conformity with
generally accepted accounting principles requires the Company to make estimates
and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Some areas where the Company makes estimates include
allowance for doubtful accounts, credit memo reserve, accrued employee health
and welfare benefits, contingent liabilities, asset retirement obligations,
stock compensation expense, income tax assets and liabilities, accrued auto, and
workers' compensation insurance claims, leases, intangible asset valuations and
long-lived asset, goodwill and a held for sale impairment. Such estimates are
based on historical trends and on various other assumptions that are believed to
be reasonable under the circumstances. Actual results could differ from these
estimates.
Revenue from Contracts with Customers: Revenue is recognized when a customer
obtains control of promised goods or services. The amount of revenue recognized
reflects the consideration to which the Company expects to be entitled to
receive in exchange for these good or services. Revenue is recognized net of
revenue-based taxes assessed by governmental authorities.
The Company provides RWCS, which provide collection and processing of regulated
and specialized waste, including medical, pharmaceutical and hazardous waste,
for disposal and compliance programs; SID Services, which provide for the
collection of personal and confidential information for secure destruction and
recycling of shredded paper; and CRS which includes communication services such
as appointment reminders, secure messaging, event registration and other
communications for hospitals and IDN's.
The associated activities for each of these are a series of distinct services
that are substantially the same and have the same pattern of transfer over time;
therefore, the respective services are treated as a single performance
obligation.
The Company recognizes revenue by applying the right to invoice practical
expedient as the Company's right to consideration corresponds directly to the
value provided to the customer for performance to date. Revenues for the
Company's regulated waste and secure information destruction services are
recognized upon waste collection. The Company's compliance services revenues are
recognized over the contractual service period. Revenues from communication
services are recognized as the services are performed.
2020 10-K Annual Report      Stericycle, Inc. • 63


--------------------------------------------------------------------------------

Table of Contents PART II




Accounts Receivable and Allowance for Doubtful Accounts: Accounts receivable is
recorded when billed or when goods or services are provided. The carrying value
of the Company's receivables is presented net of an allowance for doubtful
accounts. The Company estimates its allowance for doubtful accounts based on
past collection history and specific risks identified among uncollected amounts,
as well as management's expectation of future economic conditions. If current or
expected future economic trends, events, or changes in circumstances indicate
that specific receivable balances may be impaired, further consideration is
given to the collectability of those balances and the allowance is adjusted
accordingly. Past-due receivable balances are written off when the Company's
internal collection efforts have been exhausted.
No single customer accounts for more than approximately 2.1% of the Company's
accounts receivable or approximately 1.5% of total revenues. During the year
ended December 31, 2020, 2019 and 2018, bad debt expense was $21.7 million,
$25.7 million and $24.9 million, respectively.
Contract Liability: The Company records a contract liability when cash payments
are received in advance of the Company's services being performed which is
classified as current in Other current liabilities on the Consolidated Balance
Sheets since the amounts are earned within a year.
Contract Acquisition Costs: Incremental direct costs of obtaining a contract,
which primarily represent sales incentives, are deferred and amortized to SG&A
over the estimated period of benefit to be derived from the cost.
Cash and Cash Equivalents: The Company considers all highly liquid investments
with a maturity of less than three months when purchased to be cash
equivalents. Cash equivalents are carried at cost.
Financial Instruments: The Company's financial instruments consist of cash and
cash equivalents, accounts receivable and payable, and long-term debt. Financial
instruments, which potentially subject the Company to concentrations of credit
risk, consist principally of accounts receivable. Credit risk on trade
receivables is minimized as a result of the large size of the Company's customer
base, low concentration, and the performance of ongoing credit evaluations of
its customers. The Company also maintains allowances for potential credit
losses.
Property, Plant and Equipment: Property, plant and equipment is stated at cost.
Expenditures for software purchases and software developed for internal use are
capitalized and included in Software. For software developed for internal use,
external direct costs for materials and services and certain internal payroll
and related fringe benefit costs are capitalized as the costs of computer
software developed or obtained for internal use.
Depreciation and amortization is computed using the straight-line method over
the estimated useful lives of the assets as follows:
Building and improvements            2 to 40 years
Machinery and equipment              2 to 30 years
Containers                           2 to 20 years
Vehicles                             2 to 10 years

Office equipment and furniture 2 to 20 years Software

                             2 to 10 years


Capitalized Interest: The Company capitalizes interest incurred associated with
projects under construction for the duration of the asset construction period.
During the years ended December 31, 2020, 2019 and 2018, the Company capitalized
interest of $1.8 million, $5.4 million and $2.9 million, respectively.

Goodwill and Other Identifiable Intangible Assets: Goodwill represents the
excess of the purchase price over the fair value assigned the net tangible and
identifiable tangibles of business acquired. Intangible assets with definite
lives are amortized on a straight-line basis over their estimated useful lives.
Certain permit indefinite-lived intangible assets may become definite-lived to
the extent event and circumstance warrant.
Impairment of Long - Lived Assets:
Property and Equipment and Intangible Assets (definite-lives), Net: Long-lived
assets, such as property, plant and equipment and amortizing intangible assets
are reviewed whenever events or changes in circumstances indicate that the
related carrying amounts may not be recoverable. Impairment of assets with
definite-lives is generally determined by comparing projected undiscounted cash
flows expected to be generated by the asset, or asset groups, to its carrying
value. If the carrying value of the long-lived asset or asset group is not
recoverable on an undiscounted basis, an impairment is recognized to the extent
fair
2020 10-K Annual Report      Stericycle, Inc. • 64

--------------------------------------------------------------------------------

Table of Contents PART II




value exceeds carrying value. Determining the extent of impairment, if any,
typically requires various estimates and assumptions including cash flows
directly attributable to the asset, the useful life of the asset and residual
value, if any. When necessary, the Company uses internal cash flow estimates,
quoted market prices and appraisals as appropriate to determine fair
value. Actual results could vary from these estimates. In addition, the
remaining useful life of the impaired asset is revised, if necessary.
Intangible Assets (indefinite-lived): Indefinite-lived intangibles consist
primarily of permits and tradenames. Indefinite-lived intangibles are assessed
for impairment annually as of October 1, or more frequently if an event occurs
or circumstances change, using either a qualitative or quantitative approach.
The qualitative approach first determines if it is more-likely-than-not that the
fair value of the asset is less than the carrying value.  If no such
determination is made, then the impairment test is complete.  If, however, it is
determined that there is a likely impairment, a quantitative assessment is
performed. The Company performs its annual impairment test on indefinite-lived
intangibles, using the qualitative approach for certain assets and the
quantitative approach for the remaining assets.
Goodwill: Goodwill is assessed for impairment at least annually as of October 1
of each year, or more frequently if an event occurs or circumstances change that
would reduce the fair value of a reporting unit below its carrying value.
The Company uses a quantitative approach to assess goodwill for impairment. The
fair value of each reporting unit is calculated using the income approach
(including DCF) and validated using a market approach with the involvement of a
third-party valuation specialist. The Company's reporting units are: Domestic
RWCS, Domestic SID, Domestic CRS, Canada, Europe, Asia Pacific and Latin
America. The income approach uses expected future cash flows of each reporting
unit and discounts those cash flows to present value.  Expected future cash
flows are estimated using management assumptions of growth rates, including
long-term growth rates, capital expenditures and cost efficiencies.  Future
acquisitions or divestitures are not included in the expected future cash
flows. The Company uses a discount rate based on a calculated weighted average
cost of capital which is adjusted for each of its reporting units based on size,
country and company specific risk premiums.  The market approach compares the
valuation multiples of similar companies to that of the associated reporting
unit.  The Company then reconciles the calculated fair values to its market
capitalization. The fair value is then compared to its carrying value including
goodwill. If the fair value is in excess of its carrying value, the related
goodwill is not impaired. If the fair value is less than carrying value, an
impairment charge is recognized, equivalent to the amount that the carrying
value exceeds the fair value but not to exceed the carrying value of the
goodwill.
The use of different assumptions, estimates or judgments in the goodwill
impairment testing process may significantly increase or decrease the estimated
fair value of a reporting unit. Generally, changes in DCF estimates would have a
similar effect on the estimated fair value of the reporting unit. The Company
believes that the estimated fair value used in measuring the impairment was
based on reasonable assumptions but future changes in the underlying assumptions
could differ due to the inherent judgment in making such estimates.
Goodwill impairment charges may be recognized in future periods to the extent
changes in factors or circumstances occur, including deterioration in the
macro-economic environment or in the equity markets, including the market value
of the Company's common shares, deterioration in its performance or its future
projections, or changes in its plans for one or more reporting units.
Assets and Liabilities Held-for-Sale: Long-lived assets or disposal groups are
classified as held-for-sale when management having the appropriate authority,
generally the Company's Board of Directors or certain of its Executive Officers,
commits to a plan of sale, the disposal group is ready for immediate sale, an
active program to locate a buyer has been initiated and the sale is probable and
expected to be completed within one year. Once classified as held-for-sale
disposal groups are valued at the lower of their carrying amount or fair value
less estimated selling costs. Where the disposal group constitutes substantially
all of our operations of a foreign country, the balance in the cumulative
translation adjustment associated with that country is included in the carrying
value of the disposal group. If the carrying value, including any amount
associated with the cumulative translation adjustment, exceeds the fair value
less estimated selling costs a held-for-sale impairment charge is recorded to
reduce the carrying value.
2020 10-K Annual Report      Stericycle, Inc. • 65

--------------------------------------------------------------------------------

Table of Contents PART II




The estimate for fair value is reviewed at the end of every reporting period
that the disposal group is classified as held-for-sale and the carrying value
adjusted whenever the estimated fair value less costs to sell is less than the
carrying value.
Insurance and Self-Insurance: The Company's insurance for workers' compensation,
auto/fleet, general liability, property, and employee-related health care
benefits is obtained using high deductible insurance policies, if any, meaning
that the Company has retained a significant portion of the risks related to the
claims associated with these programs. The estimated exposure for unpaid claims
and associated expenses, including incurred but not reported losses, is based on
a calculation performed by a third party actuarial specialist using the
Company's historical claims experience. The accruals for these liabilities could
be revised if future occurrences or loss developments significantly differ from
the assumptions used. Estimated recoveries associated with insured claims are
recognized as assets when the receipt of such amounts is probable.
Restructuring Charges: Involuntary termination benefits are accrued upon the
commitment to a termination plan and when the benefit arrangement is
communicated to affected employees, or when liabilities are determined to be
probable and estimable, depending on the existence of a substantive plan for
severance or termination. Costs for one-time termination benefits in which the
employee is required to render service beyond a minimum retention period in
order to receive the benefits are recognized ratably over the future service
period. Contract termination costs are recognized when contracts are terminated
or when the Company ceases to use the leased facility and no longer derive
economic benefit from the contract. All other exit costs are expensed as
incurred.
Stock-Based Compensation: The Company recognizes stock-based compensation
expense based on the estimated grant-date fair value. Expense is generally
recognized on a straight-line basis over the service period during which awards
are expected to vest. The Company presents stock-based compensation expense
within the Consolidated Statements of Loss based on the classification of the
respective employees' cash compensation.
Income Taxes: The Company is subject to income taxes in both the U.S. and
numerous foreign jurisdictions. The Company computes its provision for income
taxes using the asset and liability method, under which deferred tax assets and
liabilities are recognized for the expected future tax consequences of temporary
differences between the financial reporting and tax basis of assets and
liabilities and for operating loss and tax credit carry-forwards. Deferred tax
assets and liabilities are measured using the currently enacted tax rates that
are expected to apply to taxable income for the years in which those tax assets
and liabilities are expected to reverse. Significant judgments are required in
order to determine the realizability of these deferred tax assets. In assessing
the need for a valuation allowance, the Company evaluates all significant
available positive and negative evidence, including historical operating
results, estimates of future taxable income and the existence of prudent and
feasible tax planning strategies. Changes in the expectations regarding the
realization of deferred tax assets could materially impact income tax expense in
future periods. Tax liabilities are recognized when, in management's judgment,
an uncertain tax position does not meet the more likely than not (i.e. a
likelihood of more than fifty percent) threshold for recognition. For tax
positions that meet the more likely than not threshold, a tax liability may
still be recognized depending on management's assessment of how the tax position
will ultimately be settled. The Company records interest and penalties on
unrecognized tax benefits in the provision for income taxes.
Leases: Operating leases are included in Operating lease ROU assets, Operating
lease liabilities and Long-term operating lease liabilities on the Company's
Consolidated Balance Sheets. Finance leases are included in Property, plant and
equipment, Current portion of long-term debt and Long-term debt on the
Consolidated Balance Sheets.
Operating lease ROU assets, Operating lease liabilities and Long-term operating
lease liabilities are recognized based on the present value of the future
minimum lease payments over the lease term at commencement date. Nearly all of
the Company's lease contracts do not provide a readily determinable implicit
rate. For these contracts, the Company uses an estimated incremental borrowing
rate, which is based on information available at lease commencement.
The Company's leases generally do not contain material variable lease payments
and generally do not contain options to purchase the leased property, any
material residual value guarantees, or material restrictive covenants. At
commencement, the Operating lease ROU asset is equal to the lease liability and
is adjusted for lease incentives and initial direct costs incurred. The Company
reviews all options to extend, terminate, or purchase its ROU assets at the
commencement of the lease and on an ongoing basis and accounts for these options
when they are reasonably certain of being exercised. Lease expense is recognized
on a straight-line basis over the lease term.
2020 10-K Annual Report      Stericycle, Inc. • 66


--------------------------------------------------------------------------------

Table of Contents PART II




The Company has lease agreements with lease and non-lease components, including
payments for common area maintenance and vehicle maintenance costs, which are
accounted for separately, based on their underlying nature, for each class of
underlying assets.
In addition, the Company applies the short-term lease recognition exemption
for leases with terms at commencement of not greater than 12 months.
Asset Retirement Obligations: The Company establishes assets and liabilities for
the present value of estimated future costs to retire long-lived assets at the
termination or expiration of a lease. Such assets are amortized over the lease
term and the recognized liabilities are accreted to the future value of the
estimated retirement costs. The related amortization and accretion expenses are
presented within COR if the leased asset is used in the delivery of the
Company's services and the remaining expenses are presented within SG&A on the
Consolidated Statements of Loss.
Foreign Currency: Assets and liabilities of foreign affiliates that use the
local currency as their functional currency are translated at the exchange rate
on the last day of the accounting period and income statement accounts are
translated at the average rates during the period. Related translation
adjustments are reported as a component of accumulated other comprehensive loss
on the Consolidated Balance Sheets. Foreign currency gains and losses resulting
from transactions that are denominated in currencies other than the entity's
functional currency, including foreign currency gains and losses on intercompany
balances that are not of a long-term investment nature, are included within
Other expense, net on the Consolidated Statements of Loss.
Highly Inflationary Economy: Effective July 1, 2018, as a result of the
three-year cumulative inflation exceeding 100%, Argentina was classified as a
highly inflationary economy. Accordingly, the Company recognized, in Other
expense, net, a foreign exchange loss of $1.2 million, $3.3 million, and $3.8
million during the years ended December 31, 2020, 2019, and 2018, respectively,
arising from the re-measurement of its Argentinian peso denominated net monetary
assets. Argentina operations were divested in August 2020.
Nonmonetary assets, liabilities, and related expenses are measured using
historical exchange rates and do not fluctuate with changes in the local
exchange rate.
Adoption of New Accounting Standards
Financial Instrument Credit Losses

In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" ("ASU
2016-13") associated with the measurement of credit losses on financial
instruments. ASU 2016-13 replaces the prior incurred loss impairment methodology
of recognizing credit losses when a loss was probable, with a methodology that
reflects expected credit losses and requires consideration of a broader range of
reasonable and supportable information to assess credit loss estimates. The
amended guidance was effective for the Company on January 1, 2020. The Company
recognized a net decrease to Retained earnings in the Consolidated Financial
Statements of $2.5 million as of January 1, 2020 for the cumulative effect of
adopting ASU 2016-13.

Implementation Costs Incurred in a Cloud Computing Arrangement



In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other -
Internal Use Software (Subtopic 350-40): Customer's Accounting for
Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service
Contract" ("ASU 2018-15"). ASU 2018-15 aligns the requirements for capitalizing
implementation costs incurred in a hosting arrangement that is a service
contract with the requirements for capitalizing implementation costs for
internal-use software. The accounting for any hosting contract is unchanged. ASU
2018-15 was effective on January 1, 2020 and was adopted prospectively for
implementation costs incurred after the date of adoption. The adoption of ASU
2018-15 did not have a material impact on the Consolidated Financial Statements.
Accounting Standards Issued But Not Yet Adopted
Simplifying the Accounting for Income Taxes
In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740):
Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). ASU 2019-12
attempts to simplify aspects of accounting for franchise taxes and enacted
changes in tax laws or rates and clarifies the accounting for transactions that
result in a step-up in the tax
2020 10-K Annual Report      Stericycle, Inc. • 67


--------------------------------------------------------------------------------

Table of Contents PART II




basis of goodwill. ASU 2019-12 is effective for public business entities for
fiscal years beginning after December 15, 2020, including interim periods within
that fiscal year. The Company will adopt ASU 2019-12 effective January 1, 2021.
The ASU is not expected to have a material impact upon adoption on January 1,
2021 on our Consolidated Financial Statements.
NOTE 2 - REVENUES FROM CONTRACTS WITH CUSTOMERS


The Company provides RWCS, which provide collection and processing of regulated
and specialized waste, including medical, pharmaceutical and hazardous waste,
for disposal and compliance programs; SID Services, which provide for the
collection of personal and confidential information for secure destruction and
recycling of shredded paper; and CRS which includes communication services such
as appointment reminders, secure messaging, event registration and other
communications for hospitals and IDN's.
The Company's customers typically enter into a contract for the provision of
services on a regular and scheduled basis, e.g. weekly, monthly or on an as
needed basis over the contract term. Under the contract terms, the Company
receives fees based on a monthly, quarterly or annual rate or fees based on
contractual rates depending upon measures including the volume, weight, and type
of waste, number and size of bins collected, weight and type of shredded paper,
and number of call minutes.
Amounts are invoiced based on the terms of the underlying contract either on a
regular basis, e.g. monthly or quarterly, or as services are performed and are
generally due within a short period of time after invoicing based upon normal
terms and conditions for our business type and the geography of the services
performed.
Disaggregation of Revenue
In millions
                                                   Year Ended Year Ended December 31,
                                                   2020                2019           2018
Revenue by Service
Regulated Waste and Compliance Services   $     1,806.6             $ 2,187.8      $ 2,261.8
Secure Information Destruction Services           745.3                 901.9          911.0
Communication and Related Services                123.6                 219.2          313.1
Total Revenues                            $     2,675.5             $ 3,308.9      $ 3,485.9
North America
Regulated Waste and Compliance Services   $     1,427.6             $ 1,762.8      $ 1,778.5
Secure Information Destruction Services           647.3                 769.5          778.6
Communication and Related Services                114.3                 207.6          286.0
Total North America Segment               $     2,189.2             $ 2,739.9      $ 2,843.1
International
Regulated Waste and Compliance Services   $       379.0             $   425.0      $   483.3
Secure Information Destruction Services            98.0                 132.4          132.4
Communication and Related Services                  9.3                  11.6           27.1
Total International Segment               $       486.3             $   569.0      $   642.8


Contract Liabilities
Contract liabilities at December 31, 2020 and 2019 were $8.8 million and $12.2
million, respectively. Substantially all of the contract liabilities as of
December 31, 2020 are expected to be recognized as revenue during the year
ending December 31, 2021 and substantially all of the balance as of December 31,
2019 was recognized as revenue during the year ended December 31, 2020.
Contract Acquisition Costs
The Company's incremental direct costs of obtaining a contract, which consist
primarily of sales incentives, are deferred and amortized to SG&A over a
weighted average estimated period of benefit of 6.4 years.
During the year ended December 31, 2020, 2019, and 2018 the Company amortized
$10.6 million, $9.1 million, and $6.9 million, respectively, of deferred sales
incentives to SG&A.
Total contract acquisition costs, net of accumulated amortization, were
classified as follows as of December 31:
2020 10-K Annual Report      Stericycle, Inc. • 68


--------------------------------------------------------------------------------


  Table of Contents         PART II


In millions
                                      2020        2019
Other current assets                $ 11.1      $  9.5
Other assets                          31.1        28.9

Total contract acquisition costs $ 42.2 $ 38.4





NOTE 3 - ACQUISITIONS


Acquisitions
There were no acquisitions in the year ended December 31, 2020. During the years
ended December 31, 2019 and 2018, the Company completed 1 and 21 acquisitions,
respectively. All of the acquisitions, which were primarily in the North America
segment with revenues in the SID service line, are considered to be
complementary to existing operations and fit with the Company's growth strategy.
All were accounted for as business combinations under the applicable guidance.
The results of operations of these acquired businesses have been included in the
Consolidated Statements of Loss from the date of the acquisition. Pro forma
results of operations for these acquisitions are not presented because the pro
forma effects, individually or in the aggregate, were not material to the
Company's consolidated results of operations.
The following table summarizes the acquisition date fair value of consideration
transferred for acquisitions completed during the years ended December 31:
In millions
                          2020      2019        2018
Cash                     $  -      $ 0.2      $ 44.8
Promissory notes            -        0.3        30.0
Deferred consideration      -          -         0.6
Total purchase price     $  -      $ 0.5      $ 75.4

The fair value of consideration transferred in a business combination is allocated to the net tangible and identifiable intangible assets at the acquisition date, with the remaining unallocated amount recognized as goodwill.

NOTE 4 - RESTRUCTURING, DIVESTITURES, AND IMPAIRMENTS

Stericycle is focused on driving long-term growth, profitability and delivering
enhanced shareholder value.
Restructuring - Business Transformation
In 2017, the Company initiated a comprehensive multi-year Business
Transformation. Through December 31, 2019, the Company has incurred all the
originally anticipated employee termination charges, including incremental
charges related principally to executive management, in connection with its
initial restructuring estimate.
During the year ended December 31, 2019 and 2018, the Company recognized $5.5
million and $3.7 million in charges related to executive and employee
termination costs, of which the majority in 2019 in Other, and in 2018 in the
North America segment.
In addition, during the year ended December 31, 2018, the Company recognized
non-cash impairment charges of $9.1 million, of which $7.4 million related to
software and $0.3 million related to other long-term assets in the North America
reportable segment, that was included in COR and $1.4 million related to Other,
was included in SG&A.
Restructuring - Operational Optimization
The Company aims to achieve a culture of continuous improvement that will
enhance its efficiency, effectiveness and competitiveness to improve its cost
base and cash flow, and the company has taken a number of actions to reduce
operating costs and optimize operations. As part of these efforts, the company
seeks to reduce network redundancies by consolidating facilities and
restructuring the operations for efficiency.
2020 10-K Annual Report      Stericycle, Inc. • 69


--------------------------------------------------------------------------------

Table of Contents PART II




During the year ended December 31, 2020, the Company recognized $3.1 million of
Operational Optimization costs within our International segment related to the
discontinuation of a service line in the U.K.
During the year ended December 31, 2019, the Company recognized $14.5 million of
Operational Optimization costs. The North America segment recognized
$3.8 million of costs in the RWCS operations primarily related to a site
relocation and costs in the Domestic CRS operations related to a headcount
reduction and a non-cash impairment of intangible assets as a result of the exit
from a business line. The International segment recognized $10.7 million of
costs related to site closures and facility exit charges across the EMEA and
LATAM regions.
Divestitures
The Company incurred the following impairments and divestiture losses (gains),
net, which are included in the Consolidated Statements of Loss:
In millions
                                                     Year Ended December 31,
                                                  2020           2019         2018
North America Segment
Domestic Environmental Solutions business    $    53.8         $     -      $    -
CRS business                                     (38.8)           45.5           -
U.S. clean room business                             -               -         6.9
Total North America charges, net                       15.0         45.5       6.9
International Segment
CRS business                                      (4.0)              -           -
Argentina operations                             112.4               -           -
Mexico operations                                 (4.9)           43.2           -
Chile operations                                   5.1            19.0           -
U.K. businesses                                      -            (4.7)        5.9
Total International charges, net                 108.6            57.5      

5.9



Divestiture losses (gains), net              $   123.6         $ 103.0      $ 12.8


North America Segment:

On December 1, 2020, the Company entered into an agreement and completed the
sale of the Company's global product recall business (Expert Solutions) for cash
consideration of approximately $78.0 million. Expert Solutions business had
revenues of approximately $75.4 million for the year ended December 31, 2019,
primarily reported in North America, as part of Communication and Related
Services. The Company recognized a gain on divestment of $38.8 million in North
America and $4.0 million in International, inclusive of $2.7 million of related
deal costs for the transaction. In connection with the closing, the Company
entered into certain additional ancillary agreements, including a TSA.
On April 6, 2020, the Company completed the sale of all of the outstanding
equity interests of its Environmental Solutions business for approximately
$462.5 million, pursuant to the Purchase Agreement, dated February 6, 2020. The
Purchase Agreement provided for the divestiture of the Company's Environmental
Solutions business, exclusive of the Company's healthcare hazardous waste
services and unused consumer pharmaceutical take-back services. The
Environmental Solutions business generated revenue in 2019 of $559.6 million,
including approximately $100.0 million related to the Retained Business, which
is included in the RWCS revenue category within our North America segment. In
connection with the Purchase Agreement, the Company entered into an HSA and TSA
with the Buyer for a period of 7 years and 6 months, respectively. The Company
allocated and deferred a portion of the Transaction proceeds, $17.7 million
related to the HSA and $1.5 million related to the TSA, which will be recognized
over the applicable duration of the HSA and TSA periods, subject to specific
agreement provisions, thereby offsetting the expenses incurred to deliver the
respective services. The allocated proceeds are reflected as an operating cash
flow on the Consolidated Statement of Cash Flows, as they are advances received
for services to be provided prospectively.

In 2020, the Company recognized impairment charges and subsequent loss on disposal of $53.8 million, inclusive of $11.1 million of related deal costs for the Transaction. Further, the Company released a $1.7 million benefit 2020 10-K Annual Report Stericycle, Inc. • 70

--------------------------------------------------------------------------------

Table of Contents PART II

associated with contingent consideration related to a prior acquisition agreement connected with the divested business (Fair value - Level 3) that is reported in SG&A in the Company's Consolidated Statements of Loss.

In 2019, the Company completed the sale of the TAS business and its retail pharmaceutical returns business in the U.S. and Puerto Rico for total cash consideration of $36.4 million, resulting in total losses of $45.5 million.



In connection with the sale agreement for the TAS business, the Company entered
into a TSA with the buyer for a period of up to 15 months. The Company allocated
and deferred $5.1 million of the proceeds, which will be recognized over the
duration of the TSA period offsetting the expenses incurred to deliver the TSA
services that are not reimbursed by the buyer.
In 2018, the Company completed the sale of the non-core clean room business
realizing proceeds of $17.0 million, resulting in impairment charges and
subsequent loss on disposal totaling $6.9 million.
International Segment:
In August 2020, the Company entered into an agreement and completed the sale of
its operations in Argentina for proceeds of approximately $3.9 million. Revenue
of Argentina operations were approximately 1% of our consolidated annual
revenues for 2019. The transaction resulted in a loss on disposal of
$112.4 million, of which $87.2 million related to the balance of cumulative
currency translation adjustment.

Additionally, in December 2020, the Company recognized a $4.9 million gain
related to a divestiture of a subsidiary in Mexico, and a $5.1 million charge
associated with the divested business in Chile (see Note 12 - Commitments and
Contingencies in the Consolidated Financial Statements).
During 2019, the Company had the following divestiture activity:
•U.K. based texting business, for proceeds of $14.8 million, resulting in a gain
of approximately $5.1 million.
•A reduction in the provision against a loan receivable originally arising from
the sale of our U.K. patient transport business, resulting in a $0.3 million
gain.
•Substantially all of the Company's operations in Mexico for nominal
consideration, resulting in impairment charges and subsequent loss on disposal
totaling $43.2 million, including the realization of a loss of approximately
$18.9 million related to the balance of cumulative currency translation
adjustment.
•The Company's operations in Chile for net proceeds of $30.7 million, resulting
in a loss of $19.0 million, including the realization of a loss of approximately
$16.8 million related to the balance of cumulative currency translation
adjustment.
During 2018, the Company completed the sale of its hazardous waste business in
the U.K. for proceeds of $11.5 million of which $8.2 million was received in
cash and $3.0 million was held in escrow, until it was received in August 2019.
The Company recognized impairment charges and subsequent loss on disposal
totaling $16.5 million including additional charges of $0.7 million in 2019.
Impairments:
2020 10-K Annual Report      Stericycle, Inc. • 71

--------------------------------------------------------------------------------


  Table of Contents         PART II


In millions
                                         Year Ended December 31,
                                       2020           2019        2018
Impairments
Operational Optimization - COR    $            -    $  5.6      $    -
Operational Optimization - SG&A              2.8       1.7        12.3
Asset Impairment - COR                       6.8       5.2        17.6
Asset Impairment - SG&A                      8.7      16.9         8.9
Total Impairments                 $         18.3    $ 29.4      $ 38.8
North America
Operational Optimization - COR    $            -    $  2.0      $    -
Operational Optimization - SG&A                -       0.4         1.0
Asset Impairment - COR                       6.1       1.6        17.6
Asset Impairment - SG&A                      4.2       0.5           -

Total North America Segment $ 10.3 $ 4.5 $ 18.6 International Operational Optimization - COR $

            -    $  3.6      $    -
Operational Optimization - SG&A              2.8       1.3        11.3
Asset Impairment - COR                       0.7       3.6           -
Asset Impairment - SG&A                      4.5      16.4         8.9
Total International Segment       $          8.0    $ 24.9      $ 20.2


Operational optimization impairments are associated with the Company's actions
to reduce operating costs and optimize operations. In the year ended
December 31, 2020, the Company's International reportable segment includes
charges primarily related to the discontinuation of a service line in the U.K.
In the year ended December 31, 2019, the Company's International reportable
segment includes charges related to impairments of permits and other long-lived
assets in Europe and Latin America and in our North America reportable segment
for charges associated with a site movement. In the year ended December 31,
2018, non-cash impairment charges related to customer relationship and permit
intangibles, which were impaired as a result of actual and forecasted business
declines, primarily in LATAM.

Asset impairments in the year ended December 31, 2020, for the Company's North
America reportable segment includes charges associated with rationalization of
software application assets and intangible assets as a result of a
discontinuation of a certain service line, and the Company's International
reportable segment includes charges associated with certain property, plant and
equipment assets and permits primarily in the U.K. In the year ended
December 31, 2019, the Company's International reportable segment included
non-cash impairment charges related to customer lists and other long-lived
assets in Brazil associated with an impairment review of its operations. In the
year ended December 31, 2018, non-cash impairment charges related to software
were in connection with the Company's evolving future information systems
strategy, including the implementation of a global ERP system, and the impact on
currently deployed software as well as rationalization of applications used
within each reportable segment.
2020 10-K Annual Report      Stericycle, Inc. • 72


--------------------------------------------------------------------------------

Table of Contents PART II

NOTE 5 - PROPERTY, PLANT AND EQUIPMENT




Property, plant and equipment consisted of the following at December 31:
In millions
                                                        2020          2019
Land and improvements                                $   38.7      $   66.0
Building and improvements                               225.0         263.3
Machinery and equipment                                 323.0         342.4
Vehicles                                                156.0         177.9
Containers                                              249.7         246.6
Office equipment and furniture                           53.9         111.5

Software and Enterprise Resource Planning system 88.6 84.3 Construction in progress

                                196.1         174.3
Total property, plant and equipment                   1,331.0       1,466.3
Less: accumulated depreciation                         (629.7)       

(667.8)


Property, plant and equipment, net                   $  701.3      $  798.5


Depreciation expense was $108.6 million, $127.6 million, and $125.6 million for
the years ended December 31, 2020, 2019, and 2018, respectively.
Property, plant and equipment impairment charges included in SG&A and COR for
the years ended December 31, 2020, 2019, and 2018, respectively are further
described in Note 4 - Restructuring, Divestitures, and Impairments in the
Consolidated Financial Statements.
NOTE 6 - LEASES


The Company has operating leases for vehicles, transfer sites, processing
facilities, communication centers, corporate and regional offices, and certain
equipment.
The components of net lease cost were as follows for the years ended
December 31:
In millions
                                  2020         2019
Operating lease cost            $ 114.2      $ 117.2
Finance lease cost:
Amortization of leased assets       4.7          3.5
Interest on lease liabilities       1.9          1.0
Net lease cost                  $ 120.8      $ 121.7


Short-term lease cost, variable lease cost, and sublease income were not
significant during the years ended December 31, 2020 and 2019.
Supplemental cash flow information related to leases were as follows for the
years ended December 31:
In millions
                                                                      2020                  2019

Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases

$      117.1          $      122.4
Operating cash flows from finance leases (interest)                       1.9                   0.9
Financing cash flows from finance leases (principle)                      4.3                   4.3

Right-of-use assets obtained in exchange for lease obligations:
Operating leases                                                         79.8                 203.8
Finance leases                                                            1.1                  17.0


2020 10-K Annual Report      Stericycle, Inc. • 73

--------------------------------------------------------------------------------

Table of Contents PART II




Finance lease assets, net of accumulated amortization, were $24.8 million and
$30.1 million as of December 31, 2020 and 2019, respectively, and are included
in Property, Plant and Equipment, net on the Consolidated Balance Sheet.
Information regarding lease terms and discount rates as of December 31 were as
follows:
In millions
                                                   2020        2019
Weighted average remaining lease term (years):
Operating leases                                      6.1         6.4
Finance leases                                       14.4        15.3
Weighted average discount rate:
Operating leases                                  4.07  %     4.11  %
Finance leases                                    5.15  %     5.34  %


Maturities of lease liabilities as of December 31, 2020, were as follows:
In millions
                                      Operating leases       Finance leases
2021                                 $            86.2      $           3.7
2022                                              83.8                  3.7
2023                                              67.7                  4.0
2024                                              58.0                  2.8
2025                                              39.6                  2.5
Thereafter                                       100.6                 23.3
Total lease payments                             435.9                 40.0
Less: Interest                                    50.8                 15.2
Present value of lease liabilities   $           385.1      $          24.8


As of December 31, 2020, the Company had additional operating leases of $1.6
million which have not yet commenced. These operating leases are expected to
commence in fiscal year 2021 with lease terms of 10 years.
NOTE 7 - GOODWILL AND OTHER INTANGIBLE ASSETS


Goodwill:

The changes in the carrying amount of goodwill were as follows: In millions


                                                          North America           International                  Total
Balance as of December 31, 2018                         $      2,848.4          $        373.8                $ 3,222.2
Purchase accounting adjustments                                   (4.3)                      -                     (4.3)
Impairments during the year                                     (207.4)                  (20.9)                  (228.3)
Divestitures                                                      (2.4)                   (6.2)                    (8.6)
Changes due to foreign currency fluctuations and other            (2.7)                    3.9                      1.2
Balance as of December 31, 2019                                2,631.6                   350.6                  2,982.2

Divestitures                                                    (182.8)                   (4.0)                  (186.8)
Changes due to foreign currency fluctuations and other               -                    23.9                     23.9
Balance as of December 31, 2020                         $      2,448.8          $        370.5                $ 2,819.3


Accumulated non-cash impairment charges by segment as of December 31 were as
follows:
2020 10-K Annual Report      Stericycle, Inc. • 74

--------------------------------------------------------------------------------


  Table of Contents         PART II


In millions
                    2020         2019
North America     $ 421.1      $ 501.9
International       175.6        171.6

Total             $ 596.7      $ 673.5


2020 Impairments
The Company performed its annual goodwill impairment assessment as of October 1,
2020 and determined no reporting units' carrying values were in excess of their
estimated fair value.
2019 Impairments
The Company performed its annual goodwill impairment assessment as of October 1,
2019 and determined that the Environmental Solutions and Canada reporting units'
carrying values were in excess of their estimated fair value.
Factors that contributed to the estimated fair value of the reporting units
being below their carrying values included:
•Environmental Solutions: During 2019, we experienced higher operating costs,
particularly related to hazardous waste disposal costs. In addition, we
anticipate that the timeline for achieving the betterment plans for both revenue
quality and cost improvements has been extended. The Company also gathered
insights from the process of evaluating Environmental Solutions as part of the
Company's portfolio rationalization criteria.
•Canada: During 2019, we experienced competitive pricing pressure in both SID
and RWCS, lower SOP pricing, higher regulated waste costs including Canada-
based operating costs due to a reliance on third-party disposal, and U.S.-based
enabling support costs. The company expects these challenges to have a prolonged
impact and the company has adjusted them in current year long-range plan.
These challenges were factored into updates to the Company's long-range plan and
forecasted cash-flow assumptions. The Company also made certain adjustments to
the risk premiums within the discount rates used to present value these
forecasted cash-flows. As a result, the Company recognized $80.8 million of
non-cash impairment charges related its Environmental Solutions reporting unit
and $126.6 million to fully impair the goodwill associated with its Canada
reporting unit.
During the first quarter of 2019, there were business and market developments
and insights gathered from the Company's portfolio rationalization
considerations, which negatively impacted the estimated cash flows of the
Company's Latin America reporting unit and triggered an interim assessment as of
March 31, 2019. The Company determined that the Latin America reporting unit's
carrying value was in excess of its estimated fair value and recognized $20.9
million of non-cash goodwill impairment charges related to the Latin America
reporting unit.  Following the impairment, the Latin America reporting unit
goodwill was fully impaired.
2018 Impairments
The Company performed its annual goodwill impairment assessment as of October 1,
2018 and an interim assessment as of December 31, 2018. The Company determined
that the Domestic CRS and Latin America reporting units' carrying values were in
excess of their estimated fair values.
Factors that contributed to the estimated fair value of the reporting units
being below their carrying value included:
•Domestic CRS: The Company experienced a progressive decrease in revenues and
operating margins in 2018 due to (i) continued declines in large recall events
leading to a higher level of uncertainty of these occurring in future periods,
(ii) recall events that had a smaller number of units and significantly lower
revenue per event than experienced in recent years, and (iii) continued decline
in the volume of inbound/outbound call volumes for the live voice services. The
Company also gathered insights from its portfolio rationalization considerations
which were initiated in 2018.
•Latin America: The Company continued to experience prolonged challenges and
volatility in certain markets due to declining market trends and cost pressures.
Revenue increases in the M&I business due to inflationary price increases in
Argentina were offset by the impact of currency devaluation and the continuing
declines in several local economies.

2020 10-K Annual Report Stericycle, Inc. • 75

--------------------------------------------------------------------------------

Table of Contents PART II




These challenges were factored into updates to the Company's forecasted
cash-flow assumptions during the fourth quarter of 2018 to reflect its current
outlook and the Company made certain adjustments to the discount rates used to
present value these forecasted cash-flows. As a result of these impairment
assessments, the Company recognized $286.3 million of non-cash goodwill
impairment charges to fully impair the Domestic CRS reporting unit. In addition,
the Company recognized $72.4 million of non-cash goodwill impairment charges
related to the Latin America reporting unit.

The fair value of reporting units, used in both the annual and any interim
goodwill impairment assessments in 2020, 2019 and 2018, are classified as Level
3 measurements within the fair value hierarchy due to significant unobservable
inputs such as discount rates, projections of revenue, cost of revenue and
operating expense growth rates, long-term growth rates and income tax rates. The
fair value methodology is described further in Note 1 - Basis of Presentation
and Summary of Significant Accounting Policies.
Other Intangible Assets:
At December 31, the values of other intangible assets were as follows:
In millions
                                                            2020                                                             2019
                                 Gross Carrying          Accumulated                              Gross Carrying          Accumulated
                                     Amount              Amortization           Net Value             Amount              Amortization           Net Value
Amortizable intangibles:
Customer relationships           $   1,314.9          $         630.2          $   684.7          $   1,460.8          $         575.8          $   885.0
Covenants not-to-compete                 3.5                      3.0                0.5                  4.9                      3.8                1.1
Operating permits                       11.5                      6.5                5.0                  4.1                      1.6                2.5
Tradenames                               3.6                      1.3                2.3                  3.6                      1.1                2.5
Other                                    0.6                      0.6                  -                  8.6                      2.6                6.0
Indefinite-lived intangibles:
Operating permits                       79.6                        -               79.6                211.1                        -              211.1
Tradenames                             315.3                        -              315.3                314.2                        -              314.2
Total                            $   1,729.0          $         641.6          $ 1,087.4          $   2,007.3          $         584.9          $ 1,422.4

The changes in the carrying amount of intangible assets were as follows: In millions


                                                                 Total
Balance as of December 31, 2018                               $ 1,637.7
Intangible assets acquired during the year                          0.5
Reclassification of capitalized permit costs                        7.7

Purchase accounting adjustments for prior year acquisitions 4.2 Divestitures

                                                      (67.5)
Impairments during the year                                       (17.7)
Amortization during the year                                     (145.2)
Changes due to foreign currency fluctuations                        2.7
Balance as of December 31, 2019                                 1,422.4

Divestitures                                                     (209.8)
Impairments during the year                                       (11.1)
Amortization during the year                                     (124.9)
Changes due to foreign currency fluctuations                       10.8
Balance as of December 31, 2020                               $ 1,087.4


The Company's indefinite-lived intangible assets include operating permits and
certain tradenames. The Company has determined that certain of our operating
permits and certain tradenames have indefinite lives due to our ability to renew
them with minimal additional cost and therefore they are not amortized.
The impairment charges included in SG&A and COR for the years ended December 31,
2020, 2019, and 2018, respectively, are further described in Note 4 -
Restructuring, Divestitures, and Impairments.
2020 10-K Annual Report      Stericycle, Inc. • 76


--------------------------------------------------------------------------------

Table of Contents PART II




Finite-lived intangible assets are amortized over their estimated useful lives
using the straight-line method with each category having weighted average
remaining useful lives as follows:
In years
                                                                                                  Weighted average
                                                                               Estimated useful   remaining useful
                                                                                     lives             lives
Customer relationships                                                                      10-25              7.8
Covenants not-to-compete                                                                        5              3.0
Operating permits                                                                               2              2.0
Tradenames                                                                                  15-40             16.4
Landfill air rights                                                                          5-10              3.2


The useful life of intangible assets is assessed annually to determine whether
events and circumstances warrant a revision to their remaining useful life and
changes are reflected prospectively as the intangible asset is amortized over
the revised remaining useful life.  In the fourth quarter of 2020, we performed
the annual assessment of the useful life of our finite-lived intangibles and no
changes were required.
During the years ended December 31, 2020, 2019, and 2018, our aggregate
intangible asset amortization expense was $124.9 million, $145.2 million, and
$130.3 million, respectively.
Our estimated intangible asset amortization expense for each of the next five
years is as follows for the years ended December 31:
In millions
2021   $ 116.9
2022     115.6
2023     112.2
2024     110.8
2025      90.3


NOTE 8 - ACCRUED LIABILITIES




Accrued liabilities consisted of the following at December 31:
In millions
                                       2020         2019
Compensation                         $  97.6      $  68.6
Self-insurance                          78.1         74.7
Taxes                                   51.2         50.7
Interest                                19.4         21.3
Professional fees                       11.2         22.1
Disposal and landfill liabilities        1.6         18.8
Other                                   30.3         40.4
Total accrued liabilities            $ 289.4      $ 296.6




2020 10-K Annual Report      Stericycle, Inc. • 77

--------------------------------------------------------------------------------


  Table of Contents         PART II


NOTE 9 - DEBT

Long-term debt consisted of the following at December 31: In millions


                                                                         2020               2019
$1.2 billion senior credit facility, due in 2022                     $   173.3          $   758.7
$1.3 billion term loan, due in 2022                                      422.5            1,172.2
$600 million Senior Notes, due in 2024                                   600.0              600.0
$500 million Senior Notes, due in 2029                                   500.0                  -

Promissory notes and deferred consideration, weighted average maturity of 2.12 and 2.49 years for 2020 and 2019, respectively 42.3

               73.1

Foreign bank debt, weighted average maturity of 1.1 years for 2020 and 1.6 years for 2019

                                                    32.3               42.2
Obligations under finance leases (Note 6)                                 24.8               30.4
Total debt                                                             1,795.2            2,676.6
Less: current portion of total debt                                       91.0              103.1
Less: unamortized debt issuance costs                                     15.1               14.2
Long-term portion of total debt                                      $ 

1,689.1 $ 2,559.3

The weighted average interest rates on long-term debt, excluding finance leases, as of December 31, were as follows:


                                                                       2020 

2019

$1.2 billion senior credit facility, due in 2022 (variable rate) 2.03 % 3.57 % $1.3 billion term loan, due in 2022 (variable rate)

                   1.90  %     3.44  %
$600 million Senior Notes, due in 2024 (fixed rate)                   5.38  %     5.38  %
$500 million Senior Notes, due in 2029 (fixed rate)                   3.88  %        -  %
Promissory notes and deferred consideration (fixed rate)              1.79  %     1.81  %
Foreign bank debt (variable rate)                                     2.03  

% 4.43 %




Senior Notes
On November 9, 2020, the Company issued $500.0 million at par of aggregate
principal Senior Notes, due January 2029, which are unsecured and bear interest
at 3.875% per annum, payable on January 15 and July 15 of each year. The Senior
Notes are fully and unconditionally guaranteed by each of the issuer's current
and, subject to certain exceptions, future domestic subsidiaries that guarantee
the issuer's senior credit facility, term loan facility, or certain other debt
of the issuer or the subsidiary guarantors.
The 2020 Senior Notes will be redeemable, in whole or in part, at any time, and
from time to time, on or after November 15, 2023, at the redemption prices
specified under "Description of Notes-Optional Redemption", plus accrued and
unpaid interest, if any, to, but excluding, such redemption date. At any time
and from time to time prior to November 15, 2023, the notes may be redeemed, in
whole or in part, at a redemption price of 100% the principal amount thereof,
plus a "make-whole" premium, plus accrued and unpaid interest, if any, to, but
excluding, the redemption date. In addition, the issuer may redeem up to 40% of
the notes at any time and from time to time before November 15, 2023, with the
net cash proceeds from certain equity offerings at a redemption price equal to
103.875%, plus accrued and unpaid interest, if any, to, but excluding, the
redemption date.
In connection with the issuance of the 2020 Senior Notes, the Company incurred
$5.8 million of direct issuance costs, which have been capitalized in
unamortized debt issuance costs and are being amortized to Interest expense, net
over the term of the 2020 Senior Notes.
During 2019, the Company issued $600.0 million at par of aggregate principal
Senior Notes, due July 2024, which are unsecured and bear interest at 5.375% per
annum, payable on January 15 and July 15 of each year. The Senior Notes are
fully and unconditionally guaranteed by each of the Company's current domestic
subsidiaries that guarantee the Company's Senior Credit Facility. The Indenture
limits the ability of the Company and its subsidiaries to incur certain liens,
enter into certain sale and leaseback transactions, and consolidate, merge or
sell all or substantially all of their assets.

2020 10-K Annual Report Stericycle, Inc. • 78

--------------------------------------------------------------------------------

Table of Contents PART II




The 2019 Senior Notes will be redeemable, at the option of the Company, in whole
or in part, at any time on or after July 15, 2021, at the redemption prices
specified in the Indenture along with accrued interest. At any time prior to
July 15, 2021, the Senior Notes may be redeemed, at the option of the Company,
in whole or in part, at a redemption price of 100% of the principal amount
thereof, plus a "make-whole" premium, and accrued and unpaid interest. In
addition, the Company may redeem up to 40% of the Senior Notes at any time
before July 15, 2021, with the net cash proceeds from certain equity offerings
at a redemption price equal to 105.375%, plus accrued and unpaid interest.

In connection with the issuance of the 2019 Senior Notes, the Company incurred
$7.1 million of debt issuance costs, which have been capitalized in unamortized
debt issuance costs and are being amortized to Interest expense, net over the
term of the 2019 Senior Notes.

In the event of both a change of control of the Company and a rating downgrade
by the rating agencies, the Company will be required to offer to repurchase all
outstanding 2020 and 2019 Senior Notes at 101% of their principal amount, plus
accrued and unpaid interest.

The Indentures contains customary events of default, which include (subject in
certain cases to customary grace and cure periods), nonpayment of principal or
interest; breach of other agreements in the Indenture; failure to pay certain
other indebtedness; certain events of bankruptcy or insolvency; failure to pay
certain final judgments; and failure of certain guarantees to be enforceable.
Credit Agreement
The Company maintains a Credit Agreement which, as amended, provided for a term
loan facility of $950 million and a revolving credit facility of $1.2 billion.
On February 25, 2020, the Company executed a Fifth Amendment, which amended the
Credit Agreement to, among other things:
•increase the maximum allowable Consolidated Leverage Ratio to 5.00 to 1.00
until December 31, 2021 and 4.50 to 1.00 thereafter.
•upon the consummation of the divestiture of the Environmental Solutions
business, each of the foregoing maximum permitted Consolidated Leverage Ratio
levels were reduced to 4.75 to 1.00 until December 31, 2021 and 4.25 to 1.00
thereafter.
•allow for continuation of the $200.0 million of cash add backs to EBITDA
through December 31, 2020, and addbacks of $100.0 million until December 31,
2021, with no further addbacks thereafter.
•increase the leverage ratio pricing tier of greater than 4.50 to 1.00
by 0.125%.
•grant a first-priority security interest to the administrative agent for the
benefit of the lenders in substantially all of the personal property of the
Company and certain of its material domestic subsidiaries, including certain
equity interests held by those entities.

In the year ended December 31, 2020 and in connection with the Fifth Amendment,
the Company incurred issuance costs of $1.7 million, of which $0.4 million has
been charged to Interest expense, net. The remainder was capitalized as
unamortized debt issuance costs and is being amortized to Interest expense, net
over the remaining term of the Credit Agreement.

The Company may make prepayments against the amended Senior Credit Facility, in
whole or in part, without premium or penalty. The Company would be required to
prepay certain outstanding amounts in the event of certain circumstances or
transactions.

As of December 31, 2020, the Company was in compliance with its Credit Agreement
Debt Leverage Ratio covenant, with an actual ratio of 3.54 to 1.00, which was
below the allowed maximum ratio of 4.75 to 1.00 as set forth in the Fifth
Amendment. On April 6, 2020, the Company completed the divestiture of the
Environmental Solutions business. Therefore, effective April 6, 2020, the
Consolidated Leverage Ratio decreased by 0.25 to 4.75 to 1.00 for fiscal
quarters ending on or before December 31, 2021 and 4.25 to 1.00 for fiscal
quarters ending on or after March 31, 2022.
Given our current leverage position, we believe we should be able to operate
within our covenant thresholds, but due to the unpredictability of the COVID-19
pandemic and situations outside our control, it is reasonably likely we could
exceed this Consolidated Leverage Ratio threshold at some point in the next 12
months. This risk can be mitigated and potentially managed through appropriate
spending controls, divestitures, restructuring the Company's existing
indebtedness, amending the Credit Agreement, or seeking temporary relief from
the Consolidated Leverage Ratio covenant from the Company's lenders.
2020 10-K Annual Report      Stericycle, Inc. • 79


--------------------------------------------------------------------------------

Table of Contents PART II





A failure to comply with these covenant provisions could result in an event of
default. Upon an event of default, unless waived, the lenders could elect to
terminate their commitments, cease making further loans, and/or cause their
loans to become due and payable in full, foreclose against the assets securing
the debt under our Credit Agreement, and force us and our subsidiaries into
bankruptcy or liquidation.
Other Matters
Amounts committed to outstanding letters of credit and the unused portion of our
Senior Credit Facility at December 31 were as follows:
In millions
                                                                 2020       

2019

Outstanding letters of credit under Senior Credit Facility $ 79.5 $ 33.0 Unused portion of the Revolving Credit Facility

                 947.2       

408.3




Payments due on long-term debt, excluding finance lease obligations, during each
of the five years subsequent to December 31, 2020 are as follows:
In millions
2021         $    87.3
2022             571.4
2023               5.1
2024             605.2
2025               0.9
Thereafter       500.5
Total        $ 1,770.4



NOTE 10 - INCOME TAXES

The U.S. and International components of income (loss) before income taxes consisted of the following for the years ended, December 31: In millions


                                   2020          2019          2018
United States                    $  65.6      $ (150.5)     $ (189.1)
Foreign                           (121.6)       (212.3)        (86.3)

Total loss before income taxes $ (56.0) $ (362.8) $ (275.4)




Significant components of the Company's income tax benefit (expense) for the
years ended December 31, are as follows:
In millions
                                      2020         2019        2018

Current


United States - federal             $ 108.3      $    -      $    -

United States - state and local (2.9) (10.7) (0.4) Foreign

                                (6.0)       (6.4)       (8.5)
                                       99.4       (17.1)       (8.9)

Deferred


United States - federal               (85.9)       23.9        24.4
United States - state and local       (13.7)        8.0        11.2
Foreign                                 0.3         2.0         3.1
                                      (99.3)       33.9        38.7
Total benefit                       $   0.1      $ 16.8      $ 29.8


A reconciliation of the income tax provision computed at the federal statutory
rate to the effective tax rate for the years ended December 31, are as follows:
2020 10-K Annual Report      Stericycle, Inc. • 80


--------------------------------------------------------------------------------


  Table of Contents         PART II


                                                              2020                    2019                    2018
Federal statutory income tax rate                                21.0  %                 21.0  %                21.0  %
Effect of:
State and local taxes, net of federal tax effect                (11.2  %)                 1.2  %                 4.2  %
Foreign tax rates                                                14.3  %                  5.1  %                 4.2  %
Permanent - other items                                          (2.1  %)                (4.2  %)                0.5  %
Permanent - goodwill impairment                                     -  %                (14.1  %)               (9.1  %)
CARES Act / Tax Act                                              79.2  %                    -  %                (3.2  %)
Valuation allowance                                             (26.5  %)                (1.2  %)               (7.5  %)
Divestitures                                                    (62.7  %)                 1.2  %                   -  %
Stock-based compensation and executive compensation
disallowance                                                    (11.9  %)                (1.0  %)                1.2  %
Other                                                             0.1  %                 (3.4  %)               (0.5  %)
Effective tax rate                                                0.2  %                  4.6  %                10.8  %

Deferred tax liabilities and assets at December 31, were as follows: In millions


                                            2020          2019
Deferred tax liabilities:
Property, plant and equipment            $  (49.0)     $  (68.1)
Goodwill and intangibles                   (391.2)       (417.9)
Leases - right of use asset                 (91.3)        (84.5)
Other                                       (17.1)        (10.9)
Total deferred tax liabilities             (548.6)       (581.4)
Deferred tax assets:
Accrued liabilities                          63.1          87.8
Leases - right of use liability              96.5          88.7

Net operating tax loss carry-forwards 49.0 116.2 Interest expense carry-forward

               11.3          31.2
Other                                        15.0          11.4
Less: valuation allowance                   (52.0)        (39.4)
Total deferred tax assets                   182.9         295.9
Net deferred tax liabilities             $ (365.7)     $ (285.5)


The valuation allowance increased $12.6 million during the year ended
December 31, 2020, primarily due to non-benefited foreign losses.
On March 27, 2020, the President signed into law the CARES Act, which is a
substantial tax-and-spending package intended to provide additional economic
stimulus to address the impact of the COVID-19 pandemic. As a result of the
CARES Act tax law changes, for the year ended December 31, 2020, we recognized a
$44.4 million tax benefit related to our ability to carryback net operating
losses to prior years that had higher tax rates. In July 2020, the Company
received a cash refund of $48.0 million, and in December 2020, the Company
received $64.2 million (of which $62.0 million was the cash refund claim, and
$2.2 million was interest income). A remaining carryback claim associated with
the finalization of the 2019 U.S. federal income tax return is currently filed
with the IRS, and the anticipated refund is less than $1.0 million.
Additionally, in further response to the COVID-19 pandemic, on December 27,
2020, the President signed the CAA 2021, which provides several business tax
relief provisions, including (1) extension of the CFC look-through rule through
2025, (2) a temporary 100% deduction for business meals paid or incurred in 2021
and 2022, and (3) extension of the WOTC through 2025. Such provisions are
generally not significant to the Company's current tax footprint; however, the
Company will continue to assess the CAA 2021 on an ongoing basis.
On December 22, 2017, the Tax Act was signed into law making significant changes
to the Internal Revenue Code. Changes included, but were not limited to, a
corporate income tax rate decrease from 35% to 21% effective for tax years
beginning after December 31, 2017, the transition of U.S. international taxation
from a worldwide tax system to a territorial system, and a one-time transition
tax on the mandatory deemed repatriation of cumulative foreign earnings as of
December 31, 2017.
2020 10-K Annual Report      Stericycle, Inc. • 81

--------------------------------------------------------------------------------

Table of Contents PART II




In accordance with SAB 118 and the Company's understanding of the Tax Act and
guidance available, the Company calculated the provisional estimate of the tax
impact of the Tax Act on its year end 2017 income tax benefit/provision and as a
result recognized an income tax benefit of $129.8 million in the fourth quarter
of 2017, the period in which the legislation was enacted. The provisional amount
related to the re-measurement of certain deferred tax assets and liabilities
based on the rates at which they are expected to reverse in the future, the
one-time transition tax on the mandatory deemed repatriation of foreign earnings
and the related expected foreign withholding taxes on such earnings are
reflected in the table below.

The net tax benefit recognized during the year ended December 31, 2017, related to the Tax Act was as follows:



In millions
Remeasurement of net deferred tax liabilities due to enacted rate reduction        $     167.7
Section 965 transition tax on foreign earnings                                           (24.3)
Foreign withholding taxes on such earnings                                               (13.6)
Net tax benefit from the Tax Act                                            

$ 129.8




During the year ended December 31, 2018, the Company adjusted the Tax Act
provisional amounts recognized as of December 31, 2017 for the one-time
transition tax, deferred taxes, and foreign withholding taxes. These adjustments
resulted in a net charge to the tax provision of $8.8 million. As of December
31, 2018, the accounting for the various elements of the Tax Act was complete.
Adjustments may be necessary in future periods due to potential technical
corrections to the Tax Act and/or regulatory guidance that may be issued by the
U.S. Internal Revenue Service.
As of December 31, 2020, the Company plans to repatriate any undistributed
earnings of its first-tier foreign subsidiaries back to the U.S. only to the
extent that they were previously taxed under the Tax Act, and future
repatriations may take the form as distributions from previously taxed earnings
and profits and/or return of capital distributions. All other undistributed
earnings, to the extent there are any, will remain permanently reinvested to
support existing working capital needs in the foreign subsidiaries. A
withholding tax, unrealized foreign exchange gain, and state income tax accrual
has been recorded, as applicable. The Company has not provided for deferred
taxes on outside basis differences for investments in its foreign subsidiaries
that are unrelated to unremitted earnings as these basis differences will be
indefinitely reinvested. A determination of the unrecognized deferred taxes
related to these other components of outstanding basis difference is not
practicable to calculate.
At December 31, 2020, the net operating loss carry-forwards from both foreign
and domestic operations are approximately $161.9 million and certain of these
net operating loss carry-forwards begin to expire in 2021. The tax benefits of
these net operating losses is approximately $49.0 million at December 31, 2020,
on which valuation allowances of $25.3 million were recognized offsetting such
tax benefits.
The Company files income tax returns in the U.S., in various states and in
certain foreign jurisdictions. We generally are no longer subject to U.S.
federal, state, local, or non-US income tax examinations by tax authorities for
years prior to 2015.
The Company has recognized liabilities to cover certain uncertain tax
positions. Such uncertain tax positions relate to additional taxes that the
Company may be required to pay in various tax jurisdictions. During the course
of examinations by various taxing authorities, proposed adjustments may be
asserted. The Company evaluates such items on a case-by-case basis and adjusts
the accrual for uncertain tax positions as deemed necessary.
The total amount of unrecognized tax benefit at December 31, 2020 is $24.3
million. The amount of uncertain tax positions that, if recognized, would affect
the effective tax rate is approximately $23.2 million. We recognized interest
and penalties related to income tax reserves as a benefit in the amount of $1.5
million, $0.7 million, and charge of $0.8 million for the years ended
December 31, 2020, 2019 and 2018, respectively, as a component of income tax
expense. It is reasonably possible that our unrecognized tax benefits will
decrease by as much as $5.0 million to $10.0 million in the next 12 months
primarily due to the progress of federal, state, and international audits.
The following table summarizes the aggregate changes in unrecognized tax
benefits:
2020 10-K Annual Report      Stericycle, Inc. • 82


--------------------------------------------------------------------------------

Table of Contents PART II




In millions
Unrecognized tax positions as of December 31, 2018             $ 64.7
Gross increases - tax positions in prior periods                  1.2
Gross increases - current period tax positions                    4.6
Settlements                                                      (0.2)
Lapse of statute of limitations                                  (7.6)
Unrecognized tax positions as of December 31, 2019               62.7

Gross increases (decreases) - tax positions in prior periods (33.5) Gross increases - current period tax positions

                    2.4
Settlements                                                      (0.8)
Lapse of statute of limitations                                  (6.5)
Unrecognized tax positions as of December 31, 2020             $ 24.3


The table above includes amounts that relate to uncertain tax positions from
acquired companies. Purchase agreements to acquire the stock of a target
generally provide that the seller is liable for and has indemnified the Company
against all income tax liabilities for periods prior to the acquisition. The
Company will be responsible for unrecognized tax benefits and related interest
and penalties for periods after the acquisition.
The Company filed a PFA with the IRS related to a claim under Internal Revenue
Code Section 1341 concerning the tax rate to be applied to the SQ Settlement on
the Company's 2018 tax return. As a result of the enactment of the CARES Act,
the Company was able to realize a benefit at the higher tax rate on a portion of
the SQ Settlement. In 2020, in consideration of the CARES Act, we revised the
PFA, a portion of the long-term receivable previously established for the
Section 1341 claim was reclassified to a current income tax receivable, and the
related uncertain tax position has been released as part of the tax benefit for
2020.
Subsequently, we amended the 2018 tax return to reduce the Section 1341 benefit
as a result of discussions with the IRS as part of the PFA program.
Consequently, the remaining long-term receivable established for the Section
1341 claim and the corresponding uncertain tax position has been reclassified to
a current income tax receivable and a current income tax liability,
respectively, as both are expected to settle within one year, and with respect
to the uncertain tax position, to settle in cash. Any additional income tax
benefit resulting from the claim in a future period may be recognized as
appropriate in accordance with the guidance in ASC 740 on the accounting for
uncertain tax positions. There can be no assurance that this amount or any
amount will be recovered as a result of this claim.
NOTE 11 - FAIR VALUE MEASUREMENTS


Fair value is defined as the price that would be received to sell an asset or
paid to transfer a liability in an orderly transaction between market
participants at the measurement date. The fair value hierarchy distinguishes
between (1) market participant assumptions developed based on market data
obtained from independent sources (observable inputs) and (2) an entity's own
assumptions about market participant assumptions developed based on the best
information available in the circumstances (unobservable inputs). The fair value
hierarchy consists of three broad levels as described below:
Level 1 - Quoted prices in active markets for identical assets or liabilities
(highest priority).
Level 2 - Observable inputs other than quoted prices in active markets for
identical assets and liabilities, quoted prices for identical or similar assets
or liabilities in inactive markets, or other inputs that are observable or can
be corroborated by observable market data for substantially the full term of the
assets or liabilities.
Level 3 - Inputs that are generally unobservable and typically reflect
management's estimate of assumptions that market participants would use in
pricing the asset or liability (lowest priority).
Financial assets and liabilities are classified in their entirety based on the
lowest level of input that is significant to the fair value measurement. Our
assessment of the significance of a particular input to the fair value
measurement requires judgment and may affect the valuation of assets and
liabilities and their placement within the fair value hierarchy levels. The
impact of our creditworthiness and non-performance risk has been considered in
the fair value measurements noted below. There were no movements of items
between fair value hierarchies in the years presented.
2020 10-K Annual Report      Stericycle, Inc. • 83


--------------------------------------------------------------------------------

Table of Contents PART II

Our contingent consideration liabilities are reassessed at the end of every reporting period and are recorded using Level 3 inputs. The amounts are classified as either other current liabilities or other liabilities and are presented as follows as of December 31: In millions


                                  2020       2019
Other current liabilities        $ 0.4      $ 0.6
Other liabilities                  5.3        7.4

Total contingent consideration $ 5.7 $ 8.0




Contingent consideration represents amounts expected to be paid as part of
acquisition consideration only if certain future events occur. The Company
arrives at the fair value of contingent consideration by applying a weighted
probability of potential payment outcomes. The calculation of these potential
outcomes is dependent on both past financial performance and management
assumptions about future performance.
If the financial performance measures were all fully met, the maximum aggregate
liability would be $8.2 million at December 31, 2020.
Changes to contingent consideration are reflected in the table below:
In millions
Contingent consideration as of January 1, 2018     $ 10.3
Decrease due to payments                             (2.3)

Contingent consideration as of December 31, 2019 8.0 Change in fair value reflected in SG&A

               (2.1)
Currency Translation Adjustment                      (0.1)
Decrease due to payments                             (0.1)

Contingent consideration as of December 31, 2020 $ 5.7




In addition to assets and liabilities that are recorded at fair value on a
recurring basis, the Company is required to record certain assets and
liabilities at fair value on a nonrecurring basis, generally as result of
acquisitions, the classification of disposal groups as held-for-sale, or the
re-measurement of assets resulting in impairment charges. See Note 3 -
Acquisitions, Note 4 - Restructuring, Divestitures, and Impairments, Note 5
Property, Plant and Equipment, and Note 7 - Goodwill And Other Intangible Assets
for further discussion of the fair value of assets and liabilities associated
with Acquisitions and Assets Held for Sale. These values are generated using
Level 3 inputs.
Fair Value of Debt: The estimated fair value of the Company's debt obligations,
using Level 2 inputs, compared to the carrying amount at December 31 was as
follows:
In billions
                                       2020        2019

Fair value of debt obligations $ 1.86 $ 2.73 Carrying value of debt obligations 1.80 2.68




The fair values were estimated using an income approach by applying market
interest rates for comparable instruments.
Accounts receivable, accounts payable, and accrued liabilities are financial
assets and liabilities, respectively, with carrying values that approximate fair
value, using Level 3 inputs.
NOTE 12 - COMMITMENTS AND CONTINGENCIES


Environmental Remediation Liabilities
The Company records a liability for environmental remediation when such
liability becomes probable and the costs or damages can be reasonably
estimated. The Company accrues environmental remediation costs, on an
undiscounted basis, associated with identified sites where an assessment has
indicated that cleanup costs are probable and can be reasonably estimated, but
the timing of such payments is not fixed and determinable. Such liabilities are
based on currently available information, estimated timing of remedial actions,
existing technology, and enacted laws and regulations.
2020 10-K Annual Report      Stericycle, Inc. • 84


--------------------------------------------------------------------------------

Table of Contents PART II




Environmental remediation liabilities in total at December 31 were presented as
follows:
In millions
                                   2020        2019
Accrued liabilities - other       $ 0.4      $  4.7
Other long-term liabilities           -        27.2

Total environmental liabilities $ 0.4 $ 31.9





The reduction in environmental liabilities relates primarily to the
Environmental Solutions business, which was sold on April 6, 2020 and included
$27.5 million of environmental remediation liabilities (see Note 4 -
Restructuring, Divestitures, and Impairments).
Asset Retirement Obligations
The Company has asset retirement obligations that it is required to perform
under law or contract once an asset is permanently taken out of service. Most of
these obligations are not expected to be paid until many years in the future and
are expected to be funded from general company resources at the time of removal.
At December 31, 2020 and 2019, the total asset retirement obligation liabilities
recognized were $19.7 million and $19.4 million, respectively and were included
in Other long-term liabilities on the Consolidated Balance Sheets.
Letters of Credit, Surety Bonds and Bank Guarantees
As of December 31, 2020 and 2019, the Company had $79.5 million and $33.0
million, respectively, of stand-by letters of credit outstanding against our
senior credit facility (see Note 9 - Debt). As of December 31, 2019, we had
$52.3 million of stand-by letters of credit outstanding against another facility
which was entered into during 2019. As of December 31, 2020, no amounts of
stand-by letters of credit were outstanding. In addition, at December 31, 2020
and 2019 we had, $37.9 million and $72.3 million, respectively, of surety bonds
and $21.2 million and $19.3 million, respectively, of bank guarantees. The bank
guarantees are issued mostly by the Company's international subsidiaries for
various purposes, including leases, seller notes, contracts and permits. The
surety bonds are used for performance and financial guarantees. Neither the bank
guarantees nor the surety bonds affect the Company's ability to use its various
lines of credit.

Indemnifications


In the ordinary course of business and in connection with the sale of assets and
businesses and other transactions, we often indemnify our counterparties against
certain liabilities that may arise in connection with the transaction or that
are related to events and activities prior to or following a transaction (see
Note 4 - Restructuring, Divestitures, and Impairments). If the indemnified party
were to make a successful claim pursuant to the terms of the indemnification, we
may be required to reimburse the loss. These indemnifications are generally
subject to various restrictions and limitations. Historically, we have not paid
material amounts under these provisions and, as of December 31, 2020, these
indemnifications obligations were not material.
NOTE 13 - RETIREMENT AND OTHER EMPLOYEE BENEFIT PROGRAMS


Defined Contribution Plans:
The Company has a 401(k) defined contribution retirement savings plan covering
substantially all domestic employees. Each participant may elect to defer a
portion of his or her compensation subject to certain limitations. The Company
may contribute up to 50% of compensation contributed to the Plan by each
employee up to a maximum of $3,000 per annum. During the years ended
December 31, 2020, 2019 and 2018, the Company's contributions were $8.7 million,
$11.0 million and $10.6 million, respectively.
The Company also has several foreign defined contribution plans, which require
the Company to contribute a percentage of the participating employee's salary
according to local regulations. During the years ended December 31, 2020, 2019
and 2018, the Company's total contributions were $4.6 million, $5.0 million and
$3.1 million, respectively.
Multiemployer Defined Benefit Pension Plans:
The Company participates in two trustee-managed multiemployer defined benefit
pension plans ("Multiemployer Pension Plans") for employees who are covered by
collective bargaining agreements. The risks of participating in these
Multiemployer Pension Plans are different from single-employer plans in that (i)
assets contributed to the Multiemployer Pension Plan by one employer may be used
to provide benefits to employees or former employees of
2020 10-K Annual Report      Stericycle, Inc. • 85


--------------------------------------------------------------------------------

Table of Contents PART II




other participating employers; (ii) if a participating employer stops
contributing to the Multiemployer Pension Plans, the unfunded obligations of the
Multiemployer Pension Plan may be required to be assumed by the remaining
participating employers and (iii) if the Company chooses to stop participating
in any of its Multiemployer Pension Plans or if any event should significantly
reduce or eliminate the need to participate (such as employee layoffs or closure
of a location), the Company may be required to pay those plans a withdrawal
amount based on the underfunded status of the plan. Based upon the most recent
information available, one of the plans the Company participates in is in
"critical" status due to an accumulated funding deficiency and has adopted a
rehabilitation plan to address the funding deficiency position.
The following table outlines the Company's participation in Multiemployer
Pension Plans:
                                                                                                                                                                                                           Expiration Date of
                                                                                                                                                                       Company Contributions (4)               Collective
                                                                                  Pension Protection Act Zone Status (1), (3)                                                (in millions)                     Bargaining
                              Plan Employer ID Number          Plan #              2020                                2019               FIP/RP Status (2)               2020               2019              Agreements
Pension Plan Private
Sanitation Union, Local 813                                                               Red/                                Red/
IBT                                          13-1975659          1                    Critical                            Critical           Implemented            $         0.6          $  0.6             various dates
Nurses And Local 813 IBT
Retirement Plan                              13-3628926          1                       Green                               Green                        N/A       $         0.1          $    -             various dates


(1)Zone status is defined by the Department of Labor and the Pension Protection
Act of 2006 and represents the level at which the plan is funded. Plans in the
red zone are less than 65% funded, while plans in the green zone are at least
80% funded. Status is based on information received from the Multiemployer
Pension Plans and is certified by the pension plans actuary.
(2)The "FIP/RP Status" column indicates Multiemployer Pension Plans for which a
Funding Improvement Plan ("FIP") or a Rehabilitation Plan ("RP") has been
implemented or is pending. The most recent Pension Protection Act zone status
available in 2020 and 2019 is for the plans' year-end December 31, 2019.
(3)A Multiemployer Pension Plan that has been certified as endangered, seriously
endangered or critical may begin to levy a statutory surcharge on contribution
rates. Once authorized, the surcharge is at the rate of 5% for the first 12
months and 10% for any periods thereafter, until certain conditions are met.
Contributing employers, however, may eliminate the surcharge by entering into a
collective bargaining agreement that meets the requirements of the applicable
FIP or RP.
(4)The Company was listed in the Form 5500 for the Pension Plan Private
Sanitation Union Local 813 IBT as individually significant for contributing more
than 5% of total contributions to such plan during the plan years ended December
31, 2019. At the date these financial statements were issued, Forms 5500 were
not available for the Multiemployer Pension Plans for the year ended
December 31, 2020.
NOTE 14 - STOCK BASED COMPENSATION


At December 31, 2020, the Company had the following incentive stock plans:
•the 2017 Plan;
•the 2014 Plan;
•the 2011 Plan;
•the 2008 Plan; and
•the 2005 Plan;
At December 31, 2020, the Company had reserved a total of 3,016,597 shares for
issuance under its incentive stock plans.
The Plans provide for the grant of NSOs, ISOs, RSUs and PSUs intended to qualify
under Section 422 of the Internal Revenue Code; and the 2000 Plan provides for
the grant of NSOs. The Plans authorize awards to the Company's officers,
employees and consultants and to the Company's directors.
The exercise price per share of an option granted under any of the Plans may not
be less than the closing price of a share of the Company's common stock on the
date of grant. The maximum term of an option granted under any of the Plans may
not exceed 8 or 10 years. An option may be exercised only when it is vested and,
in the case of an option granted to an employee (including an officer), only
while he or she remains an employee and for a limited period following the
termination of his or her employment. New shares are issued upon exercise of
stock options.
2020 10-K Annual Report      Stericycle, Inc. • 86

--------------------------------------------------------------------------------

Table of Contents




Employee Stock Purchase Plan:
In October 2000, our Board of Directors adopted the ESPP, which our stockholders
approved in May 2001 and was made effective as of July 1, 2001. The ESPP
authorizes 1,799,999 shares of our common stock, which substantially all U.S.
employees may purchase through payroll deductions at a price equal to 85% of the
fair market values of the stock as of the end of the 6 months offering
period. An employee's payroll deductions and stock purchase, may not exceed
$5,000 during any offering period. During 2020, 2019, and 2018, 70,120 shares,
97,669 shares and 131,959 shares, respectively, were issued through the ESPP. At
December 31, 2020, we had 587,705 shares available for issuance under the ESPP
plan.

Stock-Based Compensation Expense:
During 2020, there were no changes to our stock compensation plans or
modifications to outstanding stock-based awards which would change the value of
any awards outstanding.
The following table presents the total stock-based compensation expense
resulting from stock option awards, RSUs, PSUs and the ESPP and Canada ESPP
included in the Consolidated Statements of Loss:
In millions
                                      Year Ended December 31,
                                    2020            2019        2018
SG&A - stock option plans     $     3.2           $  8.0      $ 10.8
SG&A - RSUs                        15.6              7.8         7.2
SG&A - PSUs                         5.9              0.5         5.1
SG&A - ESPP and Canada ESPP         0.8              0.8         1.0
Total pre-tax expense         $    25.5           $ 17.1      $ 24.1


During the years ended December 31, 2020, 2019 and 2018, the impact of
forfeitures was a reduction to expense of $4.9 million, $6.7 million, and $3.5
million, respectively.
Stock Options:
Options granted to non-employee directors vest in one year and options granted
to officers and employees generally vest over five years. Expense related to
options with graded vesting is recognized using the straight-line method over
the vesting period.
Stock option activity for the year ended December 31, 2020 is summarized as
follows:
                                                                          Weighted Average       Weighted Average
                                                                           Exercise Price            Remaining            Total Aggregate
                                                Number of Options            per Share           Contractual Life         Intrinsic Value
                                                                                                    (in years)             (in millions)
Outstanding as of January 1, 2020                 3,967,425               $       96.32
Granted                                                   -               $           -
Exercised                                           (49,448)              $       54.21
Forfeited                                          (122,685)              $       71.95
Cancelled or expired                               (934,824)              $      102.67
Outstanding as of December 31, 2020               2,860,468               $       96.00                       2.50       $           6.7
Exercisable as of December 31, 2020               2,490,182               $      100.50                       2.00       $           2.2


At December 31, 2020, there was $3.6 million of total unrecognized compensation
expense related to stock options, which is expected to be recognized over a
weighted average period of 1.6 years.
The following table sets forth the intrinsic value of options exercised for the
years ended December 31:
In millions
                                                       2020       2019       2018

Total exercise intrinsic value of options exercised $ 0.5 $ 2.1 $ 4.7




The exercise intrinsic value represents the total pre-tax intrinsic value (the
difference between the fair value on the trading day the option was exercised
and the exercise price associated with the respective option).
2020 10-K Annual Report      Stericycle, Inc. • 87


--------------------------------------------------------------------------------

Table of Contents




There were no stock options granted in the year ended December 31, 2020. The
Company uses historical data to estimate expected life and volatility. The fair
value of stock options at the time of grant using the Black-Scholes option
pricing model was as follows:
                                                      Year Ended December 

31,


                                                             2019           

2018


Stock options granted (shares)                             340,652        

430,337


Weighted average fair value at grant date                 $  14.41       $  16.79
Assumptions:
Expected term (in years)                                         4.34           4.89
Expected volatility                                          30.99  %       25.52  %
Expected dividend yield                                       0.00  %        0.00  %
Risk free interest rate                                       2.35  %        2.64  %


Restricted Stock Units:
The fair value of RSUs is based on the closing price of the Company's common
stock on the date of grant and is amortized to expense over the service
period. RSUs vest at the end of three or five years. The 2017 Plan includes a
share reserve for RSUs granted at a 1-1 ratio while our 2008, 2011 and 2014
Plans reserve at a 2-1 ratio. No RSUs were granted under the 2005 Plan.
RSUs activity during the year ended December 31, 2020, is as follows:
                                                                         Weighted Average        Weighted Average
                                                                            Grant Date               Remaining            Total Aggregate
                                                Number of Units             Fair Value           Contractual Life         Intrinsic Value
                                                                                                    (in years)             (in millions)
Non-vested as of January 1, 2020                   439,080              $         59.09
Granted                                            574,712              $         51.82
Vested and Released                               (326,797)             $         54.63
Forfeited                                         (139,760)             $         55.72
Non-vested as of December 31, 2020                 547,235              $         54.96                       1.10       $         37.9


At December 31, 2020, there was $19.3 million of total unrecognized compensation
expense related to RSUs, which is expected to be recognized over a weighted
average period of 1.9 years. The fair value of units that vested during the
years ended December 31, 2020, 2019, and 2018 was $18.2 million, $5.3 million,
and $4.2 million, respectively.
Performance-Based Restricted Stock Units:
Our executive officers PSU program was introduced in 2017. PSUs issued to
executive officers in 2018 and 2019 vest, or not, in three equal annual
installments based on the achievement of pre-determined annual earnings per
share performance goals as approved by the Compensation Committee. Each of the
PSU's granted represent the right to receive one share of the Company's common
stock at a specified future date.
Our PSU program was expanded in 2020 to include employees in additional levels
below executive officer. PSUs issued beginning in 2020 vest, or not, at the end
of the three-year period following the grant date based on the achievement of
pre-determined annual earnings per share and annual return on invested capital
performance goals as approved by the Compensation Committee (each metric is
weighted at 50% of the whole). At the end of the three-year period, the results
from each of the three years are averaged to calculate one achievement
percentage number, and then a relative total shareholder return (rTSR) modifier
is applied to that number in order to determine the final share amount, based on
Stericycle's stock's market performance relative to performance of the S&P
MidCap 400 Index. The modifier can adjust the final shares issued by applying a
multiplier of 75% - 125%.
In addition, certain employees have been granted PSUs which vest, or not, in
four equal annual installments based on the achievement of performance goals
related to the Business Transformation, as approved by the Compensation
Committee.
Compensation cost for the executive and Business Transformation PSU's has been
recognized based on the estimated achievement of the underlying goals. The
number of PSU's that recipients will ultimately receive will be based upon the
Compensation Committee's review of the actual achievement of these goals. Each
of the PSU's granted represent the right to receive one share of the Company's
common stock at a specified future date.
2020 10-K Annual Report      Stericycle, Inc. • 88


--------------------------------------------------------------------------------

Table of Contents

PSUs activity during the year ended December 31, 2020, is as follows:


                                                                                               Weighted Average
                                                                                                  Grant Date
                                                                     Number of Units              Fair Value
Non-vested as of January 1, 2020                                         116,049              $         63.77
Granted                                                                  109,006              $         58.09
Vested and Released                                                      (38,885)             $         48.23
Forfeited (including performance goal not achieved)                      (94,128)             $         50.58
Non-vested as of December 31, 2020                                        92,042              $         57.79


The table above reflects the number of shares at target which could be granted
upon vesting of the executive and Business Transformation PSU's for which
performance goals related to 2020 have been established. At December 31, 2020,
approximately 224,000 of additional PSUs exist which will vest in tranches based
upon achievement of performance goals to be established for fiscal years 2021
and 2022.
NOTE 15 - PREFERRED STOCK


At December 31, 2020, the Company had 1,000,000 authorized shares of preferred
stock and zero shares issued and outstanding.
Series A Mandatory Convertible Preferred Stock Offering: On September 15, 2015,
the Company completed a registered public offering of 7,700,000 depository
shares, each representing a 1/10th interest in a share of 5.25% Series A
Mandatory Convertible Preferred Stock, par value $0.01 per share (the "Series A
Preferred Stock"), at a public offering price of $100.0 per depository share for
total gross proceeds of $770.0 million.
On September 14, 2018, in accordance with their terms of issue, 638,190 shares
of the Company's Series A Preferred Stock, representing all of the preferred
stock outstanding as of that date, were converted into a total of 4.7 million
shares of the Company's common stock at a ratio of 7.3394 shares of common stock
for each share of Series A Preferred Stock.
Prior to the conversion referenced above, dividends on shares of the Series A
Preferred Stock were payable on a cumulative basis when, as and if declared by
the Company's Board of Directors, or an authorized committee thereof, at an
annual rate of 5.25% on the liquidation preference of $1,000 per share (and,
correspondingly, $100.0 per share with respect to the depository shares). The
dividends were payable in cash, or subject to certain limitations, in shares of
common stock, or any combination of cash and shares of common stock, on March
15, June 15, September 15, and December 15 of each year, commencing on December
15, 2015, and to, and including, September 15, 2018.
The Company declared and paid dividends of $25.5 million to the Series A
Preferred Stock shareholders during the year ended December 31, 2018.
The following table provides information about the Company's repurchases of
depository shares of Series A Preferred stock, prior to the conversion
referenced above, during the year ended December 31, 2018:
2020 10-K Annual Report      Stericycle, Inc. • 89


--------------------------------------------------------------------------------

Table of Contents

In millions, except share and per share data


                                                          Number of
                                                      Depository Shares        Amount Paid for         Average Price
                                                         Repurchased             Repurchases           Paid per Share
January 1, 2018 - January 31, 2018                              -             $             -          $         -
February 1, 2018 - February 28, 2018                      151,900                         7.4                49.05
March 1, 2018 - March 31, 2019                                  -                           -                    -
April 1, 2018 - April 30, 2018                                  -                           -                    -
May 1, 2018 - May 31, 2018                                150,000                         7.4                49.24
June 1, 2018 - June 30, 2018                                    -                           -                    -
July 1, 2018 - July 31, 2018                                    -                              -                 -
August 1, 2018 - August 31, 2018                           50,000                         2.4                47.05
September 1, 2018 - September 30, 2018                          -                           -                    -
October 1, 2018 - October 31, 2018                              -                           -                    -
November 1, 2018 - November 30, 2018                            -                           -                    -
December 1, 2018 - December 31, 2018                            -                           -                    -
Total                                                     351,900             $          17.2          $     48.85


For the year ended December 31, 2018, repurchases of the Company's depository
shares resulted in increases in retained earnings of $16.9 million, because the
Company redeemed the depository shares at a discount. The 351,900 depository
shares repurchased during 2018 were equivalent to 35,190 shares of Series A
Preferred Stock.
NOTE 16 - LOSS PER COMMON SHARE


Basic loss per share is computed by dividing loss available to common
shareholders by the weighted-average number of shares of common stock
outstanding during the period. Diluted earnings per share is computed by
dividing income available to common shareholders by the weighted-average number
of shares of common stock outstanding during the period increased to include the
number of additional shares of common stock that would have been outstanding if
the potentially dilutive securities had been issued. Potentially dilutive
securities include outstanding stock options, shares to be purchased under the
Company's ESPP and Canada ESPP, RSUs, PSUs, and the impact of the Series A
Preferred Stock prior to conversion on September 14, 2018. The effect of
potentially dilutive securities is reflected in diluted earnings per share by
application of the "treasury stock method" for outstanding stock-based
compensation awards. Under the treasury stock method, an increase in the fair
market value of the Company's common stock can result in a greater dilutive
effect from potentially dilutive securities. For the issue of Series A Preferred
Stock, we used the "if-converted method", weighted for the period prior to
conversion. Under the if-converted method, the preferred dividend applicable to
Series A Preferred Stock was added back as an adjustment to the numerator. The
Series A Preferred Stock shares were assumed to be converted to common shares at
the beginning of the period or, if later, at the time of issuance and through
their conversion on September 14, 2018, for the year ended December 31, 2018,
these common shares are weighted for the period the Series A Preferred Stock was
outstanding with the resulting weighted average common shares included in the
denominator. In applying the if-converted method, conversion is not assumed for
purposes of computing diluted earnings per share if the effect would be
anti-dilutive. The numerator was also adjusted for any premium or discount
arising from redemption of the Series A Preferred Stock.
The following table sets forth the computation of basic and diluted (loss)
earnings per share:
2020 10-K Annual Report      Stericycle, Inc. • 90


--------------------------------------------------------------------------------

Table of Contents PART II

In millions, except per share data


                                                                    Year Ended December 31,
                                                           2020              2019              2018
Numerator:
Net loss attributable to Stericycle, Inc.               $  (57.3)         $ (346.8)         $ (244.7)
Mandatory convertible preferred stock dividend                 -                 -             (25.5)
Gain on repurchase of preferred stock                          -                 -              16.9

Numerator for basic loss per share attributable to Stericycle, Inc. common shareholders

                    $  (57.3)         $ (346.8)         $ (253.3)
Denominator:
Denominator for basic loss per share - weighted average
shares (1)                                                  91.5              91.0              87.1
Effect of dilutive securities:
Stock-based compensation awards (2)                            -                 -                 -
Mandatory convertible preferred stock (3)                      -                 -                 -
Denominator for diluted loss per share - adjusted
weighted average shares and after assumed exercises         91.5              91.0              87.1
Loss per share - Basic                                  $  (0.63)         $  (3.81)         $  (2.91)
Loss per share - Diluted                                $  (0.63)         $  (3.81)         $  (2.91)


(1)For the year ended December 31, 2018, the denominator for basic (loss)
earnings per share includes $1.4 million shares representing the
weighted-average impact of the common shares outstanding as a result of the
Series A Preferred Stock conversion on September 14, 2018.
(2)For the years ended December 31, 2020, 2019, and 2018 options to purchase
shares and awards (in thousands) of 264, 74, and 124, respectively, were
excluded from the computation of diluted (loss) earnings per share due to the
net loss incurred for the year. In periods of net loss, options, RSUs, and PSUs
are anti-dilutive and therefore excluded from the earnings per share
calculation.
(3)For the year ended December 31, 2018, the weighted average common shares (in
thousands) issuable upon the assumed conversion of the Series A Preferred Stock,
totaling 3,367, were excluded from the computation of diluted (loss) earnings
per share as such conversion would have been anti-dilutive.
The following table presents Options and RSUs that were not included in the
computation of diluted loss per share because the effect would have been
anti-dilutive under the treasury stock method.
In thousands
                                                                           Year Ended December 31,
                                                             2020                       2019                2018

Options excluded from computation of diluted loss per share.

                                                            3,017                     4,507               4,664

RSUs excluded from computation of diluted loss per share.

                                                                4                        98                 169


PSUs are offered to key employees and are subject to achievement of specified
performance conditions. Contingently issuable shares are excluded from the
computation of diluted earnings per share if, based on current period results,
the shares would not be issuable if the end of the reporting period were the end
of the contingency period. If such goals are not met, no compensation expense is
recognized, and any previously recognized compensation expense is reversed.
2020 10-K Annual Report      Stericycle, Inc. • 91


--------------------------------------------------------------------------------

Table of Contents PART II

NOTE 17 - ACCUMULATED OTHER COMPREHENSIVE LOSS




The following table sets forth the changes in the components of accumulated
other comprehensive loss:
In millions
                                                             Currency                 Unrealized Gains
                                                        Translation (Loss)          (Losses) on Cash Flow          Accumulated Other
                                                        Income Adjustments                 Hedges                  Comprehensive Loss
Balance as of January 1, 2018                           $         (283.0)         $                 (4.0)         $          (287.0)
Period change                                                      (79.3)                            1.0                      (78.3)
Balance as of December 31, 2018                                   (362.3)                           (3.0)                    (365.3)
Accelerated amortization of interest rate lock premiums                                              2.3                        2.3

Cumulative currency translation loss realized through disposition of Mexico operations

                                    18.9                               -                       18.9

Cumulative currency translation loss realized through disposition of Chile operations

                                     16.8                               -                       16.8
Period change                                                        8.5                             0.7                        9.2
Balance as of December 31, 2019                                   (318.1)                              -                     (318.1)

Cumulative currency translation loss realized through disposition of Argentina operations

                                 87.2                               -                       87.2
Period change                                                       43.5                               -                       43.5
Balance as of December 31, 2020                         $         (187.4)         $                    -          $          (187.4)



NOTE 18 - SEGMENT REPORTING


The Company evaluates, oversees and manages the financial performance of two
operating segments - North America and International.
The North America and International segments offer the following services: RWCS,
which provide collection and processing of regulated and specialized waste,
including medical (including reusable sharps disposal management services),
pharmaceutical and hazardous waste, for disposal and compliance programs (under
the Steri-Safe®, Clinical Services, First Practice Management, SeguriMed and
EnviroAssure brand names); SID Services, which provide for the collection of
personal and confidential information for secure destruction and recycling of
shredded paper; and CRS which includes communication services such as
appointment reminders, secure messaging, event registration and other
communications for hospitals and IDN's.
Beginning in 2020, we have changed our measure of segment profitability to
Adjusted Income from Operations. Adjusted Income from Operations is Income
(Loss) from Operations excluding certain specified items, including Intangible
Amortization. Also, beginning in 2020, we presented our operations in Puerto
Rico, which historically had been reported in our International reportable
segment, in our North America reportable segment. Also in 2020, we presented
U.S. CRS, which historically had been reported in Other, in our North America
reportable segment. As a result of these changes in segment reporting, all
applicable historical segment information has been recast to conform to the new
presentation.
The segments were updated to reflect how the chief operating decision maker
evaluates performance, determines resource allocation, and develops and executes
strategies to drive growth and profitability. As a result of these changes in
segment reporting, all applicable historical segment information has been recast
to conform to the new presentation.

Our reportable segments are:
•North America
•International

Other (includes costs related to corporate enabling and shared services functions, annual incentive compensation, and stock-based compensation) 2020 10-K Annual Report Stericycle, Inc. • 92

--------------------------------------------------------------------------------

Table of Contents PART II




The following tables show financial information for the Company's reportable
segments:
In millions
                                           Year Ended December 31,
                                     2020           2019           2018
Revenues
North America                     $ 2,189.2      $ 2,739.9      $ 2,843.1
International                         486.3          569.0          642.8

Total                             $ 2,675.5      $ 3,308.9      $ 3,485.9
Depreciation (1)
North America                     $    78.1      $    88.7      $    86.3
International                          21.7           27.3           29.3
Other                                   6.8            9.8           10.0
Total                             $   106.6      $   125.8      $   125.6
Intangible Amortization
North America                     $    98.3      $   111.1      $   105.1
International                          26.6           34.1           25.2
Other                                     -              -              -
Total                             $   124.9      $   145.2      $   130.3
Adjusted Income from Operations
North America                     $   606.0      $   595.0      $   754.4
International                          46.5           70.7           64.7
Other                                (263.9)        (213.7)        (200.1)
Total                             $   388.6      $   452.0      $   619.0
Total Assets
North America                     $ 4,377.5      $ 5,183.5      $ 5,212.1
International                         946.0          980.4        1,100.5
Other                                 258.4          273.1          142.9
Total                             $ 5,581.9      $ 6,437.0      $ 6,455.5


(1) Excludes depreciation of $2.0 million and $1.8 million for the year ended
December 31, 2020 and 2019, respectively, which is included as part of Business
Transformation.
The following table reconciles the Company's primary measure of segment
profitability, Adjusted Income from Operations, to Income (loss) from
operations:
In millions
                                                                     Year Ended December 31,
                                                            2020              2019              2018
Total Reportable Segment Adjusted Income from Operations $  388.6          $  452.0          $  619.0
Intangible Amortization                                    (124.9)           (145.2)           (130.3)
Business Transformation                                     (50.8)            (67.7)            (82.6)
Acquisition and Integration                                     -              (3.5)             (9.8)
Operational Optimization                                     (3.1)            (14.5)            (29.4)

Divestitures (including Divestiture Losses, net of Gains)

                                                     (133.0)           (114.7)            (20.5)
Litigation, Settlements and Regulatory Compliance           (20.3)            (28.2)            (93.2)
Asset Impairments                                           (15.5)            (22.1)            (26.5)
Goodwill Impairment                                             -            (228.3)           (358.7)
Other                                                        (9.1)            (39.7)            (29.1)
Income (loss) from operations                            $   31.9          $ (211.9)         $ (161.1)



2020 10-K Annual Report      Stericycle, Inc. • 93


--------------------------------------------------------------------------------


  Table of Contents         PART II


NOTE 19 - GEOGRAPHIC AREA


The following table presents consolidated revenues and long-lived assets by
geographic region:
In millions
                                          Year Ended December 31,
                                    2020           2019           2018
Revenues
U.S.                             $ 2,067.3      $ 2,586.8      $ 2,685.6
International:
Europe                               377.7          379.3          415.5
Other international countries        230.5          342.8          384.8
Total international                  608.2          722.1          800.3
Total                            $ 2,675.5      $ 3,308.9      $ 3,485.9
Long-Lived Assets
U.S.                             $ 4,086.0      $ 4,700.6      $ 4,505.3
International:
Europe                               632.5          636.5          612.7
Other international countries        254.5          301.0          485.4
Total international                  887.0          937.5        1,098.1
Total                            $ 4,973.0      $ 5,638.1      $ 5,603.4


NOTE 20 - LEGAL PROCEEDINGS


The Company operates in highly regulated industries and responds to regulatory
inquiries or investigations from time to time that may be initiated for a
variety of reasons. At any given time, the Company has matters at various stages
of resolution with the applicable government authorities. The Company is also
routinely involved in actual or threatened legal actions, including those
involving alleged personal injuries and commercial, employment, environmental,
tax, and other issues. The outcomes of these matters are not within the
Company's complete control and may not be known for prolonged periods of time.
In some actions, claimants seek damages, as well as other relief, including
injunctive relief, that could require significant expenditures or result in lost
revenue.
In accordance with applicable accounting standards, the Company establishes an
accrued liability for loss contingencies related to legal and regulatory matters
when the loss is both probable and reasonably estimable. If the reasonable
estimate of a probable loss is a range, and no amount within the range is a
better estimate than any other, the minimum amount of the range is accrued. If a
loss is not probable or a probable loss is not reasonably estimable, no
liability is recorded. When determining the estimated loss or range of loss,
significant judgment is required to estimate the amount and timing of a loss to
be recorded. These accruals represent management's best estimate of probable
losses and, in such cases, there may be an exposure to loss in excess of the
amounts accrued. Estimates of probable losses resulting from litigation and
regulatory proceedings are difficult to predict. Legal and regulatory matters
inherently involve significant uncertainties based on, among other factors, the
jurisdiction and stage of the proceedings, developments in the applicable facts
or law, and the unpredictability of the ultimate determination of the merits of
any claim, any defenses the Company may assert against that claim, and the
amount of any damages that may be awarded. The Company's accrued liabilities for
loss contingencies related to legal and regulatory matters may change in the
future as a result of new developments, including, but not limited to, the
occurrence of new legal matters, changes in the law or regulatory environment,
adverse or favorable rulings, newly discovered facts relevant to the matter, or
changes in the strategy for the matter. Regardless of the outcome, litigation
can have an adverse impact on the Company because of defense and settlement
costs, diversion of management resources and other factors.

Contract Class Action and Opt Out Lawsuits. Beginning on March 12, 2013, the
Company was served with several class action complaints filed in federal and
state courts in several jurisdictions. These complaints asserted, among other
things, that the Company had imposed unauthorized or excessive price increases
and other charges on its customers in breach of its contracts and in violation
of the Illinois Consumer Fraud and Deceptive Business Practices Act. The
complaints sought certification of the lawsuit as a class action and the award
to class members
2020 10-K Annual Report      Stericycle, Inc. • 94

--------------------------------------------------------------------------------

Table of Contents PART II




of appropriate damages and injunctive relief. These related actions were
ultimately transferred to the United States District Court for the Northern
District of Illinois for centralized pretrial proceedings.
The parties engaged in discussions through and overseen by a mediator regarding
a potential resolution of the matter and reached a settlement agreement, as
previously disclosed, which settlement agreement obtained court approval on
March 8, 2018 (the "SQ Settlement"). Under the terms of the SQ Settlement, the
Company admitted no fault or wrongdoing whatsoever, and it entered into the SQ
Settlement to avoid the cost and uncertainty of litigation.
Certain class members who have opted out of the Final SQ Settlement have filed
lawsuits against the Company, and the Company is defending and expects to
resolve those actions. The Company has made an accrual in respect of these
collective matters consistent with its accrual policies described above, which
is not material.
Securities Class Action and Opt Out Lawsuits. On July 11, 2016, two purported
stockholders filed a putative class action complaint in the U.S. District Court
for the Northern District of Illinois, which was subsequently amended. As
amended, the complaint purported to assert claims on behalf of all purchasers of
the Company's publicly traded securities between February 7, 2013 and February
21, 2018, inclusive, and all those who purchased securities in the Company's
public offering of depository shares on or around September 15, 2015. The
complaint named as defendants the Company, its directors and certain of its
current and former officers, and certain of the underwriters in the public
offering. The complaint purported to assert claims under Sections 11, 12(a)(2)
and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934, as well as SEC Rule 10b-5, promulgated
thereunder. The complaint alleged, among other things, that the Company imposed
unauthorized or excessive price increases and other charges on its customers in
breach of its contracts, and that defendants failed to disclose those alleged
practices in public filings and other statements issued during the proposed
class period.
Defendants filed a motion to dismiss. Before the court had ruled on the pending
motion to dismiss, the parties engaged in discussions through and overseen by a
mediator regarding a potential resolution of the matter and reached a settlement
agreement as previously disclosed (the "Securities Class Action Settlement").
The court held a final fairness hearing on July 22, 2019, at which it granted
final approval of the Securities Class Action Settlement and took under
advisement the amount of attorneys' fees to be awarded to plaintiffs' counsel
from the settlement fund. Under the terms of the Securities Class Action
Settlement, the Company admitted no fault or wrongdoing whatsoever, and it
entered into the Securities Class Action Settlement to avoid the cost and
uncertainty of litigation.
Certain class members who have opted out of the Final Securities Class Action
Settlement filed lawsuits against the Company. On March 6, 2020, the Company
filed motions to dismiss these actions. Before the courts had ruled on the
pending motions to dismiss, the parties engaged in discussions through and
overseen by a mediator and reached a settlement, which is not material, and
which was fully paid in December 2020.
U.S. Government Investigations. On June 12, 2017, the SEC issued a subpoena to
the Company, requesting documents and information relating to the Company's
compliance with the FCPA or other foreign or domestic anti-corruption laws with
respect to certain of the Company's operations in Latin America. In addition,
the DOJ notified the Company that it was investigating this matter in parallel
with the SEC. The Company is cooperating with these agencies and certain foreign
authorities. The Company also conducted an internal investigation of these and
other matters, including outside of Latin America, under the oversight of the
Audit Committee of the Board of Directors and with the assistance of outside
counsel, and this investigation found evidence of improper conduct.
As part of the FCPA investigation discussed above, the SEC has requested certain
additional information from the Company. On July 29, 2019, the SEC issued a
subpoena to the Company requesting documents relating to the Company's pricing
practices concerning small quantity customers, as alleged in the Contract Class
Actions and in the Securities Class Action. The Company is cooperating with the
SEC's request.
The Company has been informed that the office of the United States Attorney for
the Southern District of New York is conducting a False Claims Act investigation
related to Stericycle's collection, transportation and disposal of hazardous
waste. The Company is cooperating with this investigation.
The Company has separately been informed that the State of California Department
of Justice has opened an investigation related to Stericycle's collection,
transportation, and disposal of waste generated by government customers in
California. The Company is cooperating with this investigation.
The Company has not accrued any amounts in respect of the foregoing matters, as
it cannot estimate any reasonably possible loss or any range of reasonably
possible losses that the Company may incur. The Company is unable to make such
an estimate because, based on what the Company knows now, in the Company's
judgment,
2020 10-K Annual Report      Stericycle, Inc. • 95


--------------------------------------------------------------------------------

Table of Contents PART II




the factual and legal issues presented in this matter are sufficiently unique
that the Company is unable to identify other circumstances sufficiently
comparable to provide guidance in making estimates.
Environmental and Regulatory Matters. The Company is regulated by federal, state
and local laws enacted to regulate the discharge of materials into the
environment, the generation, transportation and disposal of waste, and the
cleanup of contaminated soil and groundwater and protection of the environment.
Because of the highly regulated nature of its business, the Company frequently
becomes a party to legal or administrative proceedings involving various
governmental authorities and other interested parties. The issues involved in
these proceedings generally relate to alleged violations of existing permits and
licenses or alleged responsibility under federal or state Superfund laws to
remediate contamination at properties owned either by the Company or by other
parties to which either the Company or the prior owners of certain of its
facilities shipped waste. From time to time, the Company may be subject to fines
or penalties in regulatory proceedings relating primarily to waste treatment,
storage or disposal facilities. Effective April 6, 2020, the Company completed
the divestiture of its Environmental Solutions business, including the facility
in Rancho Cordova, California, to Harsco Corporation. Pursuant to the Purchase
Agreement, the Company may be subject to certain indemnification claims for
matters relating to those Environmental Solutions facilities.
North Salt Lake, Utah. The Company and the United States DOJ have reached a
settlement in principle, subject to Court approval, to resolve an investigation
by the EPA into alleged past Clean Air Act and permit violations, as previously
alleged in the NOV issued by the State of Utah DAQ. The NOV resulted in the
Company's December 2014 settlement with the DAQ, as previously disclosed. The
federal settlement is documented in the form of a proposed civil consent decree,
which was filed with the United States District Court for the District of Utah
on January 29, 2021. If the Court approves the settlement, the Company will
undertake a Supplemental Environmental Project, in which it will provide funds
to the local Davis County School District to replace older, higher-emission
school buses with new, more efficient buses to reduce pollution and protect the
local environment, and pay a civil penalty under the Clean Air Act. The Company
has accrued the total amount of the agreement in principle, which is not
material.
Tabasco, Mexico. In 2016, the ASEA in Mexico conducted a permit compliance
inspection at a hazardous waste treatment facility acquired by one of the
Company's subsidiaries in Dos Bocas, Tabasco, Mexico. The ASEA subsequently
claimed that the Company's subsidiary did not comply with the facility's
treatment permit and issued an order imposing a fine and directing that the
facility be closed and that alleged contamination be remediated. The Company's
subsidiary engaged a firm of environmental technicians to assess the
contamination described in the ASEA order and to conduct a broader environmental
assessment of the facility. In November 2017, the ASEA rescinded the prior order
imposing the fine. After reassessing the evidence and arguments presented, the
ASEA issued a new resolution on March 9, 2018, containing a lower fine and
including remedial obligations. In March 2018, the Company submitted a proposal
for remedial measures. On April 26, 2018, the Company appealed the fines in the
order. In December 2018, the ASEA approved the Company's remediation plan.
In June 2018, the Company instituted both civil and criminal legal proceedings
in Mexico against the company from which it acquired the relevant facility,
seeking to hold the seller liable for any remediation as well as damages. In
November, 2020, the Company entered into an agreement with the prior owners of
the facility, which included the transfer and divestment of the facility and
entire subsidiary, including related obligations, back to the prior owners, and
resolving all pending litigation between the parties. The transaction closed on
December 11, 2020. As a result of the transaction, the Company has recognized
its disposal of the subsidiary including its prior accrual for the costs
necessary to comply with the ASEA order, which were not material.
Rancho Cordova, California. On June 25 and 26, 2018, the California DTSC
conducted a Compliance Enforcement Inspection of the Company's former
Environmental Solutions facility in Rancho Cordova, California. On February 14,
2020, DTSC filed an action in the Superior Court for the State of California,
Sacramento County Division, alleging violations of California's Hazardous Waste
Control Law and the facility's hazardous waste permit arising from the
inspection. That action is ongoing.
Separately, on August 15, 2019, the Company received from DTSC a written Intent
to Deny Hazardous Waste Facility Permit application for the Rancho Cordova
facility. A public hearing was held on September 22, 2019, and the public
comment period closed on October 25, 2019. The Company entered a written
submission as part of that process. On August 27, 2020, DTSC issued a Notice of
Denial of Hazardous Waste Facility Permit Application and on September 25, 2020,
the Company filed a Petition for Review, which instituted an administrative
appeal of DTSC's action, which is currently pending.
2020 10-K Annual Report      Stericycle, Inc. • 96


--------------------------------------------------------------------------------

Table of Contents PART II




The Company has not accrued any amounts in respect of these alleged violations
and cannot estimate the reasonably possible loss or the range of reasonably
possible losses that it may incur. The Company is unable to make such an
estimate because (i) litigation is by its nature uncertain and unpredictable and
(ii) in the Company's judgment, the factual and legal allegations asserted by
DTSC are sufficiently unique that it is unable to identify other proceedings
with circumstances sufficiently comparable to provide guidance in making
estimates.
DEA Investigation - Rancho Cordova, California and Indianapolis, Indiana. On
February 11, 2020, the Company received an administrative subpoena from the DEA,
which executed a search warrant at the Company's former Environmental Solutions
facility at Rancho Cordova, California and an administrative inspection warrant
at the Company's former facility in Indianapolis, Indiana for materials related
to the former Environmental Solutions business of shipping and destroying
controlled substances. On that same day, agents from the DTSC executed a
separate search warrant at the Rancho Cordova facility. The Company is
cooperating with the DEA and DTSC in response to their investigations, including
with the government's activity at the Rancho Cordova and Indianapolis
facilities.

The Company has not accrued any amounts in respect of these investigations and
cannot estimate the reasonably possible loss or any range of reasonably possible
losses that the Company may incur. The Company is unable to make such an
estimate because, based on what the Company knows now, in the Company's
judgment, the factual and legal issues presented in this matter are sufficiently
unique that the Company is unable to identify other circumstances sufficiently
comparable to provide guidance in making estimates
The Company intends to vigorously defend itself against these allegations and
actions.
European Retrovirus Investigations. In conjunction with Europol, governmental
authorities of Spain, Portugal, and Romania have conducted coordinated
inspections of a large number of medical waste management facilities, including
Stericycle facilities, relating to the transportation, management and disposal
of waste that may be infected with the COVID-19 virus, and related matters. The
inspections have resulted in proceedings in Spain and Portugal. The Company
intends to vigorously defend itself in these proceedings.

The Company has not accrued any amounts in respect of these investigations, as
it cannot estimate the reasonably possible loss or any range of reasonably
possible losses that the Company may incur. The Company is unable to make such
an estimate because, based on what the Company knows now, in the Company's
judgment, the factual and legal issues presented in this matter are sufficiently
unique that the Company is unable to identify other circumstances sufficiently
comparable to provide guidance in making estimates.
NOTE 21 - QUARTERLY FINANCIAL INFORMATION (UNAUDITED)


The following table summarizes our unaudited consolidated quarterly results of
operations as reported for 2020 and 2019:
In millions, except per share data
                                                  First                Second          Third Quarter          Fourth
                                               Quarter 2020         Quarter 2020           2020            Quarter 2020        Year 2020
Revenues                                     $       785.0          $   598.2          $    636.4          $   655.9          $ 2,675.5
Gross profit                                         286.6              229.7               267.3              269.5            1,053.1
Goodwill impairment                                      -                  -                   -                  -                  -
Divestiture losses, net of (gains)                    58.3                3.8               104.1              (42.6)             123.6
Net (loss) income attributable to
Stericycle, Inc. common shareholders                 (20.1)              (4.5)              (81.2)              48.5              (57.3)
* Basic loss per common share                $       (0.22)         $   

(0.05) $ (0.89) $ 0.53 $ (0.63) * Diluted loss per common share

              $       (0.22)         $   (0.05)         $    (0.89)         $    0.53          $   (0.63)


2020 10-K Annual Report      Stericycle, Inc. • 97

--------------------------------------------------------------------------------

Table of Contents PART II

In millions, except per share data


                                                   First                Second             Third              Fourth
                                                Quarter 2019         Quarter 2019       Quarter 2019       Quarter 2019        Year 2019
Revenues                                      $       830.1          $   845.8          $   833.1          $   799.9          $ 3,308.9
Gross profit                                          297.1              302.6              295.3              279.5            1,174.5
Goodwill impairment                                    20.9                  -                  -              207.4              228.3
Divestiture losses, net of (gains)                     (5.4)               0.3               83.2               24.9              103.0
Loss on early extinguishment of debt                      -               23.1                  -                  -               23.1
Net (loss) income attributable to
Stericycle, Inc. common shareholders                  (37.8)             (30.5)             (59.2)            (219.3)            (346.8)
* Basic loss per common share                 $       (0.42)         $   

(0.33) $ (0.65) $ (2.41) $ (3.81) * Diluted loss per common share

               $       (0.42)         $   

(0.33) $ (0.65) $ (2.41) $ (3.81)




*  EPS calculated on a quarterly basis, and, as such, the amounts may not total
the calculated full-year EPS.
2020 10-K Annual Report      Stericycle, Inc. • 98


--------------------------------------------------------------------------------


  Table of Contents         PART II


                                STERICYCLE, INC.
                SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
In millions
                                      Balance
                                     Beginning              Charges to            Other Charges/           Write-offs/             Balance End
Allowance for doubtful accounts      of Period               Expenses            (Reversals) (1)             Payments               of Period
2018                              $        65.2          $        24.9          $          (2.1)         $       (16.1)         $         71.9
2019                              $        71.9          $        25.7          $          (5.8)         $       (23.9)         $         67.9
2020                              $        67.9          $        21.7          $          (9.2)         $       (24.2)         $         56.2


(1)Amounts consist primarily of currency translation adjustments and $9.3
million relating to divestitures undertaken during 2020.
In millions
                                                                      Additions/
                                                                     (Deductions)
                                              Balance                Charged to/
Valuation Allowance on Deferred Tax         Beginning of            (from) Income            Other Changes          Balance End of
Assets                                         Period               Tax Expense(1)          to Reserves (2)             Period
2018                                     $          16.1          $          20.6          $          (1.4)         $       35.3
2019                                     $          35.3          $          13.3          $          (9.2)         $       39.4
2020                                     $          39.4          $          17.8          $          (5.2)         $       52.0


(1)2020 amount includes valuation allowances on business operations (including
the U.K. and Brazil)
(2)2020 amount consists primarily of currency translation adjustments. 2019
amount consists primarily of divestiture valuation allowances of Mexico and
Chile. 2018 amount consists primarily of valuation allowances on acquired
deferred tax assets from business combinations.
Item 9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure


None.

© Edgar Online, source Glimpses